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LC-MS/MS METHOD DEVELOPMENT FOR THE QUANTITATION OF 
METHYLMALONIC ACID USING AQUEOUS NORMAL PHASE 
CHROMATOGRAPHY 
 
by Daniel Joseph Biocini 
 
 The aim of the study was to develop a quantitative assay for methylmalonic acid 
(MMA), an important biomarker for clinical diagnosis of vitamin B12 (B12) deficiency.  
The techniques of liquid chromatography and tandem mass spectrometry (LC-MS/MS) 
are used for separation and quantitation of MMA, as well as its endogenous isomer 
succinic acid.  The MS/MS method was developed using an infusion set-up and manual 
tuning experiments.  Relevant transitions were detected for the two analytes and     
MMA-d3, then a preliminary MS/MS method was developed.  The preliminary LC 
method was further optimized.  Various gradients, mobile phases (MPs), and additive 
combinations were used across three-column chemistries.  The three-column chemistries 
chosen were representative of distinct separation modes, C18 for reverse phase, Diamond 
Hydride (DH) for aqueous normal phase (ANP), and BEH-Amide for hydrophilic 
interaction liquid chromatography.  The chromatographic parameters of peak shape, 
capacity factor (k), selectivity (𝛼), and resolution (R) were used to judge the quality of 
separation.  In conclusion, the DH column showed the best peak shape, k, and R.  The 
peak width of MMA on DH was 0.13 minutes with a symmetrical shape, and RMMA on 
DH was 4.7.  In contrast, BEH-Amide showed the best 𝛼.  Additionally, experimental 
evidence confirmed that the DH column retains by an ANP mechanism, as shown by the 
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1.1.1 Method Development in the Clinical Laboratory 
 The clinical laboratory is designed to take human body fluid samples and measure the 
concentration of various analytes to assess health or monitor disease progression.  The 
types of body fluids that might be delivered to the clinical laboratory are diverse, 
including cerebral spinal fluid (CSF), synovial fluid, respiratory secretions, stool, tissue, 
urine, and blood.  Each type of fluid can provide unique information on different disease 
processes.  Urine and blood are the two most common body fluids assayed because of the 
ease of collection and the wealth of information that can be gleaned from the 
concentrations of various biomarkers within.  Biomarkers are molecules that can be 
measured and compared to reference ranges to identify pathophysiology or confirm 
normal physiological function.  In summary, the clinical laboratory’s goal is quite simple: 
take fluid from a patient, test that fluid for the presence and concentration of various 
analytes, and report that information to the clinical staff to inform medical decision 
making.   
 The clinical laboratory is a heavily regulated environment as the results produced 
directly impact patient care and have the potential to produce harm if inaccurate.  Clinical 
laboratories in the United States are overseen by one of two organizations, the Joint 
Commission or the College of American Pathologists (CAP).  While both organizations 
have different ultimate requirements, they ensure the lab is functioning correctly and are 
the responsible entities for auditing performance every three years.  These organizations 
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then issue a laboratory with approval or accreditation, which in essence, is proof that the 
laboratory is compliant with the critical rules passed in the Clinical Laboratory 
Improvement Amendments of 1988, as well as other relevant legislation.   
 In addition to the regulatory standards imposed by these organizations, the Food and 
Drug Administration (FDA) is responsible for overseeing laboratory diagnostic testing 
equipment and method design for commercial assays.  The process for the FDA to 
approve an assay is cumbersome and, for some assays, can take years to complete.  Often 
new biomarkers come to light through research that could provide information on a 
disease process, yet no FDA approved methods exist.  In these scenarios, many 
laboratories with advanced analytical capabilities look to develop an in-house laboratory 
developed test (LDT) to address the clinical need in a timely fashion.   
 LDTs are held to a strict set of guidelines and must have acceptable documentation to 
be considered a fully validated test.  The breadth of these experiments is significant and 
includes criteria such as linearity, carryover, accuracy, and precision, as well as a method 
comparison.  Guidance on the type of experiments required is outlined in several vital 
documents published by the FDA, CAP, and the Clinical Laboratory Standards Institute 
(CLSI).  One example of specific guidance for LC-MS/MS Method Development is CLSI 
C62-A.1 The rigorous requirements for LDTs are to ensure that patient results are 
accurate and lead to informed medical decisions.  To develop an assay in a clinical 
laboratory, a thorough understanding of the regulations, biochemistry of the analyte, and 
instrumentation is required.   
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1.2.1 Methylmalonic Acid  
1.2.1.1 MMA Biochemistry 
 MMA is an endogenous organic acid that is elevated in two distinct 
pathophysiological pathways.  The presence of an increase in MMA concentration is 
typically used to diagnose B12 deficiency or the presence of an inborn error of 
metabolism, a methylmalonic acidemia.2  In a healthy individual, MMA concentrations 
are typically less than 0.40 nmol/mL; however, when an inborn error of metabolism or 
B12 deficiency is present, the concentration can rise substantially.3  The relative absence 
of MMA in the healthy population and the stark increases with these pathophysiologies 
make MMA a promising and sensitive biomarker.  In order to understand why MMA 
would increase in these two rather different conditions, which present with quite different 
symptoms, requires an in-depth look at the biochemistry of MMA.  It is worth noting that 
the increase in MMA concentrations for these two separate scenarios show quite a 
significant difference in order-of-magnitude, with the increases in methylmalonic 
acidemias being 100 to 1000-fold higher than in the case of cobalamin deficiency 
(B12).2,4,5  In addition to concentration differences between the two pathophysiologies, 
there are differences in presentation, preferred sample type, age of onset, and treatment.   
1.2.1.1.1 Methylmalonic Acidemia  
 The presence of a methylmalonic acidemia, an inborn error of amino acid 
metabolism, is usually diagnosed by a newborn screening test.  The preferred sample for 
this type of screening test is a dried blood spot on filter paper, which is then tested for 
metabolic disorders, endocrine disorders, hemoglobin disorders, and others.6  The 
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prevalence of a methylmalonic acidemia is approximately 1 in 30,000 to 1 in 50,000 live 
births.3,7  The detection at an early age for this condition is critical as the reduction of 
protein consumption can slow the build-up of MMA concentrations in blood.  The 
aberrant pathway in this condition is due to a defect or deficiency in one or several 
enzymes involved in amino acid catabolism.4,8   
 As shown in Figure 1, the breakdown of branched-chain amino acids requires several 
enzymatic steps with the final delivery of succinyl-CoA to the citric acid cycle.  
However, fault in any enzymatic step will lead to a build-up of precursors and a lack of 
progress through this biochemical pathway.  The biochemical profile of this pathology 
includes the build-up of intermediates such as MMA, as well as other metabolites of 








Figure 1. Biochemical pathway of methylmalonic acid.  The amino acid catabolism 
shown has intermediates displayed in black, enzymes displayed in blue boxes, and the 
cofactor B12 is shown in a green box.  The orange x and arrow illustrate the elevation of 
(L)-methylmalonyl-CoA when this step in the pathway is inhibited. 
 
 
  Depending on which step in the pathway has the enzymatic deficiency, patients with 























or methylmalonyl-CoA to succinyl-CoA.  One consequence of these enzymatic 
deficiencies is the prevention of branch chain amino acids’ end products from entering 
the Krebs cycle.  Although not all are displayed above, the diverse list of mutations that 
are possible include, mutations in methylmalonyl-CoA mutase, methylmalonyl-CoA 
epimerase and cobalamin A, B, C, D, F and J deficiencies.9  The block in the final step 
before the citric acid cycle, the conversion of (L)-methylmalonyl-CoA to succinyl-CoA 
as indicated by the “X” in Figure 1 results in the most substantial elevations of MMA 
concentration in blood.  The presentation and severity will vary depending on specific 
mutation or combinations of several, but many of these deficiencies can be                  
life-threatening.   
 The acute presentation in newborns, due to the massive increases in MMA, up to 
10,000 times the normal reference range results in a severe pathology, often entailing 
metabolic acidosis, hyperammonemia, and rapid deterioration.4,10  Failure to thrive is the 
blanket clinical diagnosis given to infants before laboratory findings are available, 
indicating the severity of the condition and its life-threatening nature.  Treatment for 
metabolic disorders is mainly based on avoidance of the foods that feed into defective 
pathways.  In the case of branched-chain amino acids, avoidance of whey, beef, chicken, 
fish, and whole wheat, amongst other specific foods that have elevated BCAAs, would be 
recommended.11  While B12 deficiency may be present in the newborn population, the 




1.2.1.1.2 B12 Deficiency 
 The second pathway that results in a mildly elevated MMA concentration is B12 
deficiency, which is often suspected in an older population due to a hematologic 
malignancy on a blood smear review.12  Megaloblastic anemia is the finding that suggests 
an investigation of B12 status.  Cobalamin, B12, is a cofactor for several enzymatic 
pathways in humans, including red blood cell formation and DNA production.13  A 
cofactor is needed to bind certain enzymes to make them functional.  As a cofactor, B12 
in the form of adenosylcobalamin is needed to complex with the enzyme   
methylmalonyl- coenzyme A (CoA) mutase for normal function.  In the case of B12 
deficiency, the patient may not have any enzymatic deficiencies in the biochemical 
pathway shown in Figure 1.  However, without the required B12 as a cofactor, 
methylmalonyl-CoA mutase will underperform.  Methylmalonyl-CoA mutase is 
responsible for the final step in the conversion of L-methylmalonyl-CoA to succinyl-
CoA.14  The increase in MMA concentration in B12 deficiency is mild relative to what is 
observed in the case of enzymatic defect. 
 While B12 is a cofactor for methylmalonyl-CoA mutase, a fact which is used to tie a 
rise in MMA concentration to a deficit of B12, it is also a cofactor in other enzymatic 
pathways.  B12 is also a cofactor for methionine synthase that is responsible for the 
conversion of homocysteine to methionine, which is required for red blood cell formation 
(Figure 2).   
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Figure 2.  Two important B12 dependent pathways.  B12 is an essential cofactor in DNA 
synthesis (with methionine synthase) and branched-chain amino acid catabolism (with 
methylmalonyl-CoA-mutase). 
 
 While the decrease in methionine synthase’s efficacy does result in an increase of 
homocysteine, other conditions cause this increase, making homocysteine less specific of 
a biomarker than MMA for B12 deficiency.  The lack of adequate cofactor for these 
enzymatic steps can have variable presentation depending on the severity of the B12 
deficiency.  However, the typical presentation is macrocytic anemia with neurological 
deficits.   Other conditions can cause macrocytic anemias and neurological deficits, so the 
ability to test MMA provides a more in-depth understanding of the cause of the 
pathology.   
 While it may seem logical that B12 would be the preferred test for B12 deficiency, 
this is surprisingly not the case.  B12 is mainly stored in tissues, and tissue stores can 
become depleted long before the serum value is lower than the normal reference 





















B12 Required as Cofactor
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provides less information biochemically than MMA.  Therefore, MMA is commonly 
measured as a functional biomarker of B12 status, although no FDA approved assay for 
MMA is available commercially.10  Analytical testing of MMA as a biochemical marker 
of B12 status is typically performed on a plasma sample; whole blood is centrifuged to 
separate the liquid from the cellular elements.  A typical reference range quoted in the 
literature for MMA elevation due to B12 deficiency is 60-360 nM, but this can vary 
based on the laboratory performing the testing and the testing methodology.3,5  While 
B12 deficiency is not necessarily life-threatening, like the inherited inborn errors of 
metabolism discussed previously.  Early detection is still essential as it allows for early 
treatment and often complete reversal of symptoms.  Symptoms of B12 deficiency 
include muscle weakness, anemia and neurological deficits.12  
 Treatment for B12 deficiency involves the administration of B12, either through 
changes in diet, supplementation, or injection.  The fact that many foods have B12 makes 
treatment with diet a plausible response assuming that the patient does not suffer from 
pernicious anemia (PA), which is a condition that prevents B12 absorption in the gut due 
to issues with intrinsic factor (IF).17  If the patient does suffer from lack of access to 
foods containing B12 or has issues with absorption, there are injectable options that 
circumvent these issues.  Unlike MMA elevation due to inborn errors of metabolism, 
MMA increases due to B12 deficiency are responsive to B12 supplementation.   The 
enzymes are normal, but the lack of cofactor results in the MMA build-up.  Despite the 
apparent clinical need for an assay that enables early detection of a condition that is 
treatable, B12 deficiency, few clinical laboratories can quantitate MMA in house.  One 
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may wonder if MMA is such a useful biomarker, why is there no FDA approved 
commercial assay for this analyte?   
 Before elucidating some of the challenges in assay design that result from the 
structure of MMA, it should be made clear that testing for B12 directly has a host of 
limitations.  Therefore, despite the analytical challenges of MMA measurement as a 
surrogate for B12 status, MMA is still the preferred biochemical marker to diagnose this 
condition.  The low concentration of MMA in the healthy population combined with the 
stark increases when B12 is deficient make MMA the most sensitive assay currently 
available as a functional biomarker of B12 status at the tissue level.18  There are two 
predominant issues with testing B12 directly, one is a physiological issue, and the other is 
an analytic issue.  Testing serum B12 to approximate tissue stores in patients can often be 
misleading, where values in the normal to low normal range for B12 are measured, yet 
the patient begins to develop symptoms of B12 deficit.  Analytically, the issue is the lack 
of standardized reference materials and the wide variety of platforms and methods by 
which B12 is currently tested.19  The variety of testing methods for B12 include IF-based 
automated competitive assays, microbiological assays using Lactobacillus leichmanii and 
radioimmunoassay.  The diversity of these assays, each with its own set of interferants 
and limitations, confound agreement across platforms.  Testing MMA has its own 





1.2.1.2 MMA Structure 
 The clinical utility of an FDA approved assay for MMA is clear.  However, there are 
challenges in developing this assay due to the structure of MMA and the presence of an 
endogenous interferant succinic acid (SA).    
 
Figure 3.  Structures of analytes. All analytes relevant to this study are displayed.  SA is 
succinic acid.  SA* is 2,2-dimethylsuccinic acid.  MMA is methylmalonic acid.       
MMA-d3 is the deuterated internal standard.  Structures shown prevail under acidic 
conditions. 
 
 Structurally, MMA is a dicarboxylic acid (Figure 3).  It is a small polar molecule with 
a low physiologic concentration, and its structural isomer SA is in higher concentration 
physiologically.5  The small size, polar nature, and presence of a high concentration 
endogenous interferant present challenges for several testing methodologies.  The pKa’s 
for the two carboxylic acid groups for MMA are 3.07, and 5.76.20  Ideally SA would be 
employed in method development for MMA to ensure the two endogenous isomers can 

















place of SA due to availability at Valley Medical Center laboratory.  The retention time 
of SA cannot expect to be mirrored by SA*.  However, chromatographic trends and 
investigation of this similar compound’s behavior can be used to inform the 
chromatographic control of SA.  MMA has been tested by several methods by various 
research groups; subsequently the most common methods will be compared, and the 
limitations will be discussed.   
1.2.1.3 Testing Strategies for MMA 
 The variety of testing methods for MMA in the literature includes different 
chromatography varieties with or without mass spectrometry and capillary 
electrophoresis.  MMA has been quantitated with gas chromatography combined with a 
flame ionization detector (GC-FID), gas chromatography-mass spectrometry (GC-MS), 
high-performance liquid chromatography (HPLC) and LC-MS/MS.  Another technique 
that will be discussed is immunoassay, as this is, by far, the most prominent analytical 
technique used in the clinical laboratory.  It will be shown in subsequent sections that 
although all of these techniques are used in the clinical laboratory for various analytes, 
the most promising method for the quantitation of MMA is LC-MS/MS, particularly with 
a chromatographic approach that favors retention of polar compounds.  To explain the 
literature methods in appropriate detail, a discussion of the analytical techniques 
commonly used is warranted. 
1.3.1 Brief Review of Analytical Methods in the Clinical Laboratory 
 The modern clinical laboratory is dominated mainly by immunoassay and 
spectrophotometric techniques based on Beer’s Law to quantitate analyte concentrations 
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monitored by absorbance (Figure 4, 5).  These techniques can be used in tandem or  
stand-alone fashion, such as lateral flow immunoassay or coupled chemical reactions 







Figure 4.  Immunoassay. A simple schematic displaying the specific interaction of 






Figure 5.  Beer’s Law. A schematic showing the principle and set-up of an instrument 
that uses absorbance to calculate concentration. 
 
Eq. 1.  𝑨 = 	𝝐 ∗ 𝒍 ∗ 𝒄         𝑨	 ∝ 𝒄 
 In a spectrophotometric measurement, incident light is directed at a sample, which 
will allow transmission of a fraction of that incident light inversely proportional to the 
concentration of the analyte in the sample.  In simple terms, Beer’s Law boils down to 
absorbance (A) is proportional to the concentration(c) (Figure 5).  It is possible to 
increase specificity by coupling chemical reactions with a chromogenic endpoint, or 
Antibody 
Other Substances 
Analyte of Interest 
Specific Binding  
Sample 
Light 




labeled antibodies can bind small molecules in solution to increase absorbance.  Despite 
these attempts to make spectrophotometry more specific, there is always the possibility of 
an unknown pigment in the sample matrix or unseen biomolecules that absorb at the same 
wavelength other than the analyte of interest.  Therefore, while Beer’s Law underpins 
many measurements in the clinical laboratory, there are several inherent flaws that 
chromatography, coupled with mass spectrometry, can mitigate.   
 Immunoassay is an analytical technique in which a reagent antibody is used to 
preferentially interact and bind an analyte of interest by recognizing an epitope on that 
analyte (Figure 4).  Yalow and Berson invented immunoassay in 1960, which boasted the 
specificity of this antibody-epitope interaction and was commercially available for a wide 
variety of biomolecules.21  The diversity of applications and widespread 
commercialization, including automated testing lines and the perceived specificity, have 
allowed immunoassay to be the predominant testing method in the clinical lab for the last 
sixty years.  Despite the continued antibody engineering and the significant investments 
in this technology over the years, there are several issues inherent to the technology that 
persist today.  Immunoassay suffers from specificity issues due to cross-reactivity, 
autoantibody interference, hook effect, heterophile antibodies, and standardization issues 
due to the proprietary nature of reagent antibody development.   
 Even with immunoassays known issues with specificity compared to LC-MS/MS, it 
would take a federal mandate to challenge this status quo and introduce a more powerful 
technique into the clinical laboratory.  In 1981 a US airplane crashed into the Nimitz 
aircraft carrier, prompting President Reagan to adopt an aggressive drug screening policy.  
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Immunoassay, which was the predominant testing method at the time for drugs of abuse, 
had a very high false-positive rate, making the testing unreliable.  The flaw of cross-
reactivity for immunoassay of small molecules was exposed, which prompted a 1988 
federal mandate that stated all drug of abuse testing must be performed by a confirmatory 
method such as GC-MS.22  Since this initial foothold in the late 1980s, applications for 
chromatography and mass spectrometry in the clinical laboratory have steadily grown.  
Although the sensitivity and specificity of the hyphenated techniques of GC-MS and   
LC-MS/MS are quite impressive, they still only hold niche roles in the clinical laboratory 
and have not surpassed immunoassay and spectrophotometry, the dominant techniques.   
 In order to simply demonstrate the power of combining a separation technique such 
as chromatography, with an incredibly specific measurement technique like mass 
spectrometry, consider the typical clinical sample.  A clinical sample can be blood, urine, 
or any other body fluid used to measure a specific analyte or biomolecule of interest.  The 
sample will have a matrix, which is the fluid portion of the sample, including all other 
constituents of interest other than the analyte.  Interfering substances can include any 
number of proteins, lipids, or biomolecules that may confound or interfere with an 
accurate measurement.  Each person can have a wide variation in the amounts of each of 
these substances.  Imagine a sample is taken just as it is, matrix and analyte, no 
separation performed before generating a mass spectra.  That mass-spectra would be very 
difficult to deconvolute as the analyte of interest would essentially be a needle in the 
haystack.   
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 The benefit of adding a separation modality such as chromatography allows the 
delivery of different compounds to the detector in discrete packets and drastically 
increases the signal-to-noise ratio.  As chromatography and mass spectrometry are both 
stand-alone techniques with rich histories, they will be discussed separately to explain the 
underlying theory and instrumentation.  Once they are understood in isolation, combining 
them as a powerful analytical measurement technique will be discussed.  
1.4.1 Chromatography 
1.4.1.1 History of Chromatography 
 Chromatography has become a powerful analytical technique with many applications 
that allows the separation of a complex sample into its various constituents by the 
differential interaction of the analytes with both the mobile and stationary phases.  
Currently, the term chromatography refers to a whole arm of separation science.  
However, it began as an observation regarding the migration of plant pigments by a 
Russian botanist, M.S. Tswett, at the turn of the 20th century.  The credit for beginning 
the field that eventually became chromatography is given to Tswett, for his observation 
of the differential migration of chlorophyll relative to carotenoids in a packed calcium 
carbonate column with petroleum ether as the mobile phase (MP).23  Since these humble 
beginnings, the utility of a customizable chemical separation that can deliver components 
of a complex mixture to a detector for accurate quantitation has revolutionized analytical 
chemistry.  Select chromatography applications as they apply to the field of analysis in 
the clinical laboratory will be discussed in subsequent sections.   
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1.4.1.2 Important Concepts in Chromatography 
 Over the last 100 years, the field of chromatography has blossomed into a scientific 
discipline unto itself, with its own language and doctrines, which will be examined in a 
limited fashion in this section.  A chromatographic experiment is one in which a sample, 
often a complex mixture, is mixed with a solvent and passed through a stationary phase, 
often a column.  This complex mixture will dissociate in the solvent, also known as a 
MP.  While passing through the packed column, various molecules in the mixture will 
have fleeting chemical interactions with the stationary phase particles.  There are various 
chemical interactions possible with the surface chemistry of these stationary phase 
particles, including ionic interactions, van der Waals interactions, hydrogen bonding, 
adsorption, and even partitioning into localized solvent layer particle-mobile phase 
interface.  Depending on the degree of interaction between the particles and the analytes, 
the various compounds will be retained for different lengths of time before eventual 
elution in the MP.  
 The retention time concept is a critical one in chromatography, which means time 
retained within the column.  Every chromatographic instrument will develop an output 
graph, known as a chromatograph, which will list retention time on the x-axis and some 
form of detector counts on the y-axis.  In a well-designed chromatographic experiment, 
the compounds being measured will elute independently at their defined retention times, 
and they will also elute reproducibly.  In other words, retention time can be a defining 
characteristic for an analyte, especially if internal standards are used to calculate a 
relative retention time.  An internal standard is a molecule that should ideally be nearly 
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identical to the analyte.  Isotopically labeled internal standards are popular for use when 
coupled with a mass spectrometry-based detection method.  The use of an internal 
standard that is chemically similar to the analyte of interest allows the scientist to adjust 
for small amounts of chromatographic drift using the relative retention time calculation.  
Calculating a relative retention time (RRT) will allow the retention time (RT) to remain a 
defining characteristic even in situations where the column length changes (typically in 
GC), the flow rate changes, or other parameters affecting absolute retention time are 
altered. 
Eq. 2.  𝑹𝑹𝑻 = 𝑹𝑻𝑨𝒏𝒂𝒍𝒚𝒕𝒆
𝑹𝑻𝑰𝒏𝒕𝒆𝒓𝒏𝒂𝒍	𝑺𝒕𝒂𝒏𝒅𝒂𝒓𝒅
 
 The key parameters affecting chromatographic quality, elution order, and peak shape 
can fill a whole chapter of text.  However, several key definitions are critical in 
understanding how to manipulate a separation.  In simple terms, the goal of a 
chromatographic experiment is to achieve optimal separation in the minimum time 
required.   Resolution, capacity factor, selectivity, and efficiency will be discussed as 
necessary concepts to describe a chromatographic experiment.  Resolution can be thought 
of as the ability to see two things as distinct.  For example, if two small circles were 
drawn on paper and that paper was moved farther and farther from the viewer, initially, 
the two circles would be well resolved.  However, as the distance increased, the circles 
may blend into one from the observer’s viewpoint.  In this example, the resolving power 
of the eye is limited to a certain distance.  In chromatography, resolution (R)  is defined 
as the difference in the retention time of the two peaks eluting from the column, divided 
by the peak width.  However, resolution (R) is dependent upon several variables, 
 19 
including capacity factor (k), selectivity (𝛼), and efficiency (N), as described by the 
Purnell Equation (Eq. 3).   








 To achieve excellent resolution, one must control each of the variables described in 
the Purnell Equation.  The three terms in the Purnell Resolution Equation can be related 
to efficiency, retention, and selectivity, respectively.  A suitable resolution is typically 
considered to be “baseline,” or in other words, the tails of the peak do not overlap but has 
also been numerically described as a number greater than 1 to 1.5.24  The capacity factor 
(k), is used to measure the degree of retention of a solute relative to an unretained solute 
(Eq. 4).  The selectivity of a column for two peaks is defined as the ratio of the two 
peaks’ capacity factor, with a higher number denoting greater selectivity and, in theory, 
enhanced ability to separate (Eq. 5).  However, the peaks can be too wide to resolve 
without decent efficiency despite the selectivity or capacity factor.  Efficiency is a 
concept that is described by the Van Deemter Equation. 
Eq. 4.  𝒌 = (𝒕𝒓 − 𝒕𝟎)/𝒕𝟎 
Eq. 5.  𝜶 = 𝒌𝟐
𝒌𝟏
 
1.4.1.3 Van Deemter Equation 
 The Van Deemter Equation (Eq. 6) is a mathematical expression that directly 
addresses peak shape and width, critical variables for defining the efficiency parameter in 
the Purnell Equation (Eq. 3).  The ideal peak is sharp, with no skew, allowing for the 
integration of the area underneath and subsequent accurate quantitation.  Due to the 
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principles of diffusion and mass transfer, there is a characteristic Gaussian distribution 
for ideal chromatographic peaks. 
Eq. 6.  𝑯𝑬𝑻𝑷 = 𝑨 + 𝑩
𝝁
+ 𝑪 ∗ 𝝁 
 The Van Deemter equation is composed of three parts, the A term, the B term, and 
the C term.  The A term is independent of flow rate, but the B and C terms are changed 
based on the MP flow rate (𝜇).  The A term is to account for what is known as eddy 
diffusion, which describes the reality that in a column packed with small particles, there 
are many paths that an analyte can take to reach the detector.  Since the analyte has this 
ability to take divergent paths, it would make sense that this compound will arrive at the 
detector at slightly different times, resulting in a broader peak.  A column packed with 
smaller, more uniform particles will decrease this term and result in a sharper peak, but 
this will increase back pressure to the fluidics system.   
 The second term, B term, describes longitudinal diffusion, which is the process by 
which an analyte diffuses forwards and backward from the region of high concentration 
to a lower concentration.  The B term is inversely related to MP linear velocity, as a 
faster flow rate will limit the amount of time the analyte has to diffuse longitudinally.  
Looking at the B term alone, it would seem the faster the flow rate, the sharper the peak, 
but the C term will show an unfavorable relationship with increased flow rate.   
 The last term in the Van Deemter equation, the C term, describes resistance to mass 
transfer.  The C term is increased proportionally to the linear velocity of the MP.  Mass 
transfer can be thought of the attraction and movement of as the analyte onto the 
stationary phase and then back into the MP.  As the flow rate increases, the analyte and 
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MP will travel past the stationary phase at an increasing speed, thereby decreasing the 
amount of time possible for interaction and mass transfer.  When all three of these terms 
are taken together, a parabolic function dependent on flow rate can be calculated that can 
be used to determine the ideal linear velocity for the MP to achieve the highest efficiency, 
also known as height equivalent to a theoretical plate (HETP).  It should be noted that 
efficiency is primarily defined by the flow rate and column dimensions, such as particle 
size and uniformity.  In comparison, the selectivity and capacity factors are decided 
mainly by the functional groups bonded to the stationary phase particles and the chemical 
interaction of these functional groups with the analytes in the sample.  In other words, it 
is possible to get variations in elution order, by changing column surface chemistry, 
while holding constant flow rate and particle size.  These chemical principles defined 
above can be applied in several different separation modes, a select few of which will be 
discussed in subsequent sections. 
1.4.1.4 Modes of Separation 
 While the most of this paper discusses concepts involved in LC, there is some 
description of GC in subsequent sections that necessitates a basic understanding of the 
concepts defined herein.  In general, chromatographic experiments can be either isocratic 
or gradient elution profiles.  In gas chromatography, the variable being modified during a 
chromatographic run is typically temperature, with no change in the column oven 
temperature during a run referred to as isothermal.  In LC isocratic or gradient refers to 
MP composition, with isocratic describing a constant MP composition and gradient 
representing a change in the percentage of the weak and strong MPs throughout the 
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course of the experiment.  The chromatographic modes described in the following 
sections will vary the column chemistries and MP compositions of the weak and strong 
MPs, resulting in preferential retention of various analytes.   
1.4.1.4.1 Reverse Phase vs. Normal Phase 
 Reverse-phase liquid chromatography (RP-LC) has been the clinical laboratory’s 
workhorse since the entrance of LC-MS/MS in this environment in the 1990s.  The 
typical RP-LC experiment consists of a non-polar column chemistry such as C18, with an 
aqueous or weak MP and an organic solvent as the elution or strong MP.  Typical 
aqueous MPs include water, often with the presence of buffer salts and formic acid in low 
concentrations for compatibility with detection by mass spectrometry.  In an RP-LC 
experiment, typical strong MPs are acetonitrile and methanol, often with the same buffer 
salts and formic acid as the aqueous MP.   
 The overarching concept in chromatography is that like stays with like due to the 
fleeting chemical interactions described earlier.  In general, this is simplified to elution 
based on polarity, if the column is non-polar, the greasy alkyl chains will interact most 
substantially with non-polar compounds and thus will retain those compounds with the 
greatest strength.  Suppose one considers the relative affinity for a stationary phase as 
compared to the MP.  In that case, it may become evident that an aqueous MP would not 
have the ability to interact with a non-polar molecule with greater strength than the non-
polar stationary phase.  However, as the MP composition changes throughout the 
gradient, the increased organic content of this MP can interact favorably with the analyte 
and cause the analyte to elute.  In short, an RP-LC experiment is ideal for non-polar 
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compounds.  Analytes will elute in the order of decreasing polarity, with the most polar 
compounds eluting early and the least polar eluting last.   
 Normal phase can be thought of as the opposite of RP-LC.  In a typical NP-LC 
experiment, a polar column is used to retain polar compounds.  In this case, an organic 
solvent is used as the weak MP, and a slightly more polar organic solvent is used as the 
strong MP.  In NP-LC, an example of a weak solvent is hexane, and a strong MP is 
isopropanol or ethyl acetate.  The elution order for compounds in NP-LC is opposite of 
RP-LC, the least polar elutes first, and the most polar is retained the longest, on the 
column.  NP-LC is not a very common technique in the clinical laboratory.  In contrast, 
RP-LC is the predominant technique with the most diverse column chemistries and the 
number of application notes made by manufacturers of HPLC-MS/MS instrumentation.  
While RP-LC may dominate the number of current clinical applications, it is obvious it 
has limitations to its scope of applications for polar molecules.   
 Despite the dominance of RP-LC, the reality is that many biological molecules, 
analytes in clinical assays, are polar.  The polar nature of drug metabolites and many 
other biological compounds is a result of how the liver and kidneys process molecules to 
ensure they can be excreted from the human body.  The liver has a two-phase metabolism 
that substantially increases the molecule’s polarity so that the kidneys can excrete the 
molecule in the urine.  This hepatic-renal clearance mechanism does not only affect the 
composition of urine, but as urine is simply an ultrafiltrate of blood, it affects the 
metabolite composition in blood as well.  Despite this physiological reality that much of 
that which is sought to be measured is polar, RP-LC has remained the predominant 
 24 
technique.  It has been said by Abraham Maslow in his book, the Psychology of Science, 
“if all you have is a hammer, everything begins to resemble a nail.”25  In the context of 
chromatography, the hammer has been RP-LC, but in the last couple of decades, a shift in 
understanding has opened up the idea that perhaps a hammer is not what is needed.   That 
there are better ways to address these physiological challenges than lengthy sample 
preparatory schemes to make biomolecules less polar before analysis.  Two additional 
separation modes have emerged to address the challenge of chromatographic separation 
of polar molecules, HILIC, and ANP. 
1.4.1.4.2 HILIC vs. ANP 
 In order to address the lack of representation for small-polar analytes in broad, 
untargeted assays and utilize a more substantial portion of the theoretical separation space 
available it became clear that divergence from RP-LC was necessary.26–29  Beginning in 
the early 1990s, two groups independently worked on solutions to this problem, the goal 
being a new stationary phase and chromatographic mode that could operate orthogonally 
and complementarily to RP-LC.  Alpert is credited with performing the early work on 
HILIC in 1990 which hinged on retention by a partition mechanism (Figure 6) that was a 
result of a hydrophilic stationary phase with a diffuse adsorbed water layer.27,30 
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Figure 6.  Partition mechanism in HILIC. An image representing the water layer that 
develops on a stationary phase that has silanols present.  HILIC stationary phases operate 
by a partition mechanism. Reproduced with permission.31  
 
 The MP composition in a HILIC method is an organic MP that is miscible with water 
as the weak solvent, such as acetonitrile or methanol, with water as the strong elution 
solvent.  The material used as chromatographic support in a HILIC experiment is a Type-
B silica bead, which has -Si-OH groups on the surface that encourage the formation of a 
water layer.29,32  Although HILIC is described as a multimodal retention mechanism, a 
deep water layer with hydrogen bonding suggests partition is the primary retention 
mechanism.  Another crucial distinction of HILIC chromatography is that the increase in 
salt concentration increases retention.  For example, the use of high concentrations of 
ammonium acetate of ammonium formate in the MP will cause later acidic analyte 
elution, relative to MPs with lower salt concentrations.33  The consensus for HILIC is that 
there are several flaws, such as low reproducibility, large volumes of MP required to 
equilibrate the column, and resultant negative impacts on chromatographic run time, 
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which prevent adoption as a widely used clinical tool.  However, despite some of these 
concerns, several groups have shown HILIC to be a promising method to separate polar 
molecules that can be paired with MS/MS for accurate quantitation.26  In summary, Type 
B silica particles used in HILIC, when functionalized with polar moieties can effectively 
separate and retain polar molecules and do so by a partition mechanism.  While the 
ability to separate polar analytes is a feature shared by ANP and HILIC, the mechanism 
and some of the drawbacks are not shared.  While both modes can perform a similar 
function, they do so in quite a different manner.  The significant difference in the 
retention mechanism between ANP and HILIC lies in the hydrophilicity of the silica bead 
used (Figure 7). 
 
Figure 7.  Type B vs. type C silica. On the left, a type B silica particle, on the right, the 
type C silica particle is displayed.  Note the silanols on type B versus the silica hydride 
moieties on type C silica.  Reproduced with permission.34 
 
 ANP-LC development began around the same time as HILIC, in the early 1990s, with 
preliminary work published by the Pesek group.32  The physical difference between these 
two polar separation modalities lies in the type of silica used in the column stationary 
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phase, type B – HILIC, vs. type C – ANP.  The significant difference between these two 
types of silica is the presence of various silanols in type B, with type C having silica 
hydride functional groups instead of silanols (Figure 7), which has many advantages, 
including influencing the retention mechanism.  The predominant retention mechanism in 
an ANP-LC experiment is not partition, but rather an adsorption mechanism.  The 
retention mechanism for ANP is still being investigated, and only in the last ten years 
were significant leaps in the understanding made.  This increase in understanding has 
allowed scientists to clearly distinguish ANP from HILIC, something that the prior 20 
years of research failed to do, often lumping the two techniques together.   
 A leap in understanding regarding the differences of these two techniques came about 
after Soukup et al. published a paper investigating the number of monolayers of water 
present on the stationary phases of various columns geared towards polar analytes.29,31,35  
The work of Soukup et al. is in agreement with the message professed by the Pesek 
group.  Although, HILIC and ANP may show utility for a similar class of molecules; they 
do so by very different retention mechanisms.  HILIC stationary phases were shown to 
have multiple monolayers of water present, for some columns as many as nine layers 
were measured.  Whereas, ANP stationary phases had less than a monolayer of water 
present, proving that a partition mechanism would not be possible.32,35  Figure 8 below 
shows the average number of monolayers of water on a variety of stationary phases, in an 




Figure 8.  Average monolayers of water by stationary phase.  Columns with multiple 
monolayers of water present favor retention by partition and can be defined as HILIC 
columns.  Columns with less than one monolayer follow an ANP mechanism.  
Reproduced with permission.31 
 
 This difference in retention mechanism is best understood by considering the impact 
on re-equilibration and salt concentrations required for increased retention.  Since a 
diffuse water layer is a pre-requisite for HILIC, more column volumes are required to re-
equilibrate and generate this water layer to achieve reproducibility.  In addition, salt 
concentrations must be increased in HILIC to affect increased retention, whereas the 
opposite trend is seen in ANP, less salt results in longer retention.  Interestingly, ANP is 
capable of operating in either an RP like or ANP like mode depending on solvent 
concentrations.  The dual retention mechanism possible in ANP is another differentiator 
between HILIC and ANP.32  Some challenges that both HILIC and ANP have had to 
overcome were the lack of commercially available column chemistries combined with the 
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confusion regarding the retention mechanisms.  Now that the distinction is clear, and as 
the column suite available for both of these techniques increases, the number of clinical 
applications for both ANP and HILIC is steadily growing.  In subsequent sections, select 
applications of HILIC and ANP will be discussed as they relate to MMA method 
development. 
1.4.1.5 Ultra High-Pressure Liquid Chromatography Instrumentation 
 The modern chromatographic approach is the UHPLC instrument, which is available 
from several manufacturers.  The term ultra refers to the ability of these instruments to 
withstand back-pressures as high as 15,000 PSI.  The capacity to operate at these 
pressures enables the use of small stationary phase particles, tightly packed with high MP 
flow rates.  The benefit of small particles packed densely into columns is to increase 
surface area for chemical interaction, and a high flow rate enables a shorter analysis time 
without sacrificing efficiency.  There are five typical components in a UHPLC 
instrument, including a sample manager, a column manager, a solvent manager, a 
detector, and a computer with software to operate the instrument.   
 The sample manager can be thought of as a refrigerated chamber that holds extracted 
samples in defined locations that can then be programmed into sample lists, which can be 
injected serially by an autosampler needle.  The needle draws the sample into a sample 
loop and then toggles a valve to draw up the solvent behind the sample bolus and flush 
the sample out towards the column.  The sample manager’s primary purpose is to deliver 
the sample in a specific volume at the desired temperature. 
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 The column manager’s role is to maintain the column at a fixed temperature, which 
will affect MP viscosity and other properties that can impact separation quality.  The 
instrument’s software will control the column manager.  It is possible to hold several 
columns in modern instruments, which may be utilized in several different methods and 
can be toggled between using selections made in the sample list.  The column manager’s 
primary purpose is to hold the analytical columns that contain varied stationary phases in 
a constant temperature environment, signifying the physical location where separation 
occurs. 
 The solvent manager is the heart of the LC system, as it pumps the various solvents in 
precise quantities through the instrument.  As mentioned previously, the solvent manager 
is used to provide a solvent to the sample loop to elute the sample bolus.  In addition, the 
solvent manager delivers the precise percentages of MP A and B at the correct times as 
specified by the LC method, to achieve the desired gradient.  The ability to    fine-tune 
the percentage of weak or strong MP at any given point in the chromatographic run 
imparts a significant degree of chromatographic control.  The solvent manager’s primary 
purpose is to precisely mix and deliver a desired MP composition at the desired time to 
achieve reproducible chromatographic retention and separation of analytes on the 
column. 
 In theory, the detector is a somewhat interchangeable piece as many types have been 
used historically, including ultra-violet, evaporative light scattering and mass 
spectrometry, among others.  However, for this project, MS detection is the only 
modality used, and the discussion will focus on this technology.  MS is an incredibly 
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complex and powerful technique that has evolved independently and in conjunction with 
GC and LC.  MS will be discussed in the subsequent section in detail as an understanding 
of the scientific theory is critical in understanding the scope and application of the 
project.  The detector’s primary purpose is to detect, and when possible, quantitate the 
compounds eluting from the LC column.  MS has the added advantage of providing a 
second dimension of data that can also help identify and add confidence to the 
identification, rather than relying on LC retention time alone. 
 The computer is a necessary component to perform data analysis.  It often comes with 
proprietary software that can perform various functions from modulating instrument 
settings in a pre-programmed fashion to quantitation and data review.  Before having a 
computer attached to the instrument with these capabilities, an operator would need to 
stand in front of the instrument and manipulate various dials at specific time points in the 
assay and then take paper printouts and analyze the data by some other method.  As 
computing power and data analysis tools continue to advance, the control of the 
instrumentation and the ease of data manipulation continue to make the scientist’s job 
easier.  The primary function of the computer is to operate the instrument and assist in 
data analysis. 
1.5.1 Mass Spectrometry 
 In the context of LC-MS/MS, the MS is simply referred to as the detector.  However, 
this technique has a rich history and a host of applications that make it quite an exciting 
topic of discussion.  The field of MS began at the turn of the 20th century, around the 
same time that chromatography was discovered in the botany field.   The first Nobel Prize 
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for MS was awarded to J.J Thomson in 1906 in the field of physics.36–38  It several years 
for this technique that was popular in theoretical physics to migrate to the field of 
chemistry and find utility in research by quantifying components of a mixture.  The 
transition into the clinical laboratory environment really began in the 1980s after the 
mandates Reagan rolled out as part of The Federal Drug Testing Program.22  The scope of 
mass spectrometry is vast, and applications so diverse it would be impractical to discuss 
the field’s breadth.  This section will discuss some basic definitions, instrument 
components, and the evolution of the MS in the clinical laboratory context.  The progress 
from GC-MS to LC-MS/MS, and the various advances in instrumentation allowed this 
evolution to occur.   
 A mass spectrometer is an instrument that utilizes a gas beam of ions traveling in an 
electromagnetic field to measure the m/z or mass to charge ratio of individual ionic 
species of a complex mixture.37  The basic information obtained from a mass 
spectrometer is a plot of m/z (x-axis) versus abundance (y-axis), known as a mass 
spectrum.  As all compounds have mass, measurement of anything is theoretically 
possible with mass spectrometry.  The typical answers that mass spectrometry is used to 
find in analytical chemistry include what is in a sample and how much of each 
component.  It is important to note that only charged compounds, ionic species, will be 
detected by a mass spectrometer.  The driving force in the instrument is an electric or 
magnetic field, which does not affect neutrals.   
 The basic instrument schematic includes six components (Figure 9): sample inlet, ion 
source, mass analyzer, detector, vacuum, and computer.  The individual components will 
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be discussed to describe their purpose and basic operating principles.  No attempt will be 
made to explain the breadth of possible variations that have been made to the instrument 
for varied applications, only select advancements as they pertain to the clinical laboratory 
and this research project.   




Figure 9.  Schema of MS instrument.  A simple diagram displaying parts of a mass 
spectrometer. 
 
 The inlet is the piece of the instrument where samples are introduced into the ion 
source.  These samples need to be relatively pure, as a complex mixture can produce a 
very noisy and convoluted mass spectrum that will be difficult to interpret.  There are 
numerous variations possible at the inlet; only three will be briefly touched upon herein.  
An infusion is a direct injection, typically using a small syringe, of a neat or pure solution 
into the mass spectrometer.  Many instruments come with an infusion set-up on board.  It 
is of great utility in early method development to tune the MS and observe the MS 
response to the compound without any other variables.  Most clinical samples are not 
neat, but rather body fluids, which are complex mixtures and necessitate a different type 
of sample inlet.  In the chromatography section, MS was described as the detector; 
however, in the MS section, chromatography and all the complexity in the science of 





 Two standard sample inlets are GC and LC.  GC was adopted earlier due to some 
apparent advantages, such as the compounds already being in the gas phase before entry 
into the ion source.  Additionally, the instrumentation was widely available.  However, 
GC-MS has its own set of limitations, and those will be discussed in subsequent sections.  
LC had been around for a long time before a few fundamental advances made it 
amenable for use as a sample inlet for LC-MS.  The critical advances made to enable LC-
MS to become the success it is today, including advancements in ion source technology 
and the invention of the triple quadrupole (QqQ).  The primary goal of the sample inlet is 
to deliver a sufficient amount of sample into the MS for detection and quantitation of the 
ionic species therein.   
 The next three components discussed - the ion source, the mass analyzer, and the 
detector all exist under vacuum.  The vacuum is critical because it removes room air and 
gases that could otherwise interact or collide with the ion beam and cause behavior that 
would not be expected based on the applied electric field.  The stronger the vacuum, the 
internal space is less subject to any potential interfering molecules, resulting in a greater 
mean free path of travel for the incident ions.37  A typical LC-MS/MS instrument will 
have a rough pump that is further supplemented by a turbopump to achieve a strong 
vacuum, which lowers noise and increases resolving power.  The primary purpose of the 
vacuum is to remove potential interactions inside the instrument so that only the mass 
analyzer can influence the trajectory of ions inside the ion beam.   
 The ion source has a role in producing charged species for introduction into the mass 
analyzer.  There is considerable variation in ion sources.  While most are inside the 
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vacuum as previously described, some exist outside the vacuum as well but will not be 
discussed in this paper.  To further understand the role of an ion source, a few chosen 
examples will be given, including hard and soft ionization techniques and familiar 
sources for GC-MS, LC-MS/MS, and TOF instruments.  Hard ionization techniques are 
techniques where fragmentation is considerable, due to the high energy imparted on the 
molecule, such as in electron ionization (EI).   
 Soft ionization techniques involve minimal fragmentation.  In some cases, no 
fragmentation occurs, but instead, an adduct is formed, which is the addition of weight 
through an ionic attraction of a charged species in the MP.  An example of a soft 
ionization technique is electrospray ionization (ESI).  The sample inlet provides a fine 
mist of droplets to the ion source, which is then gently evaporated and subsequently 
separated by a charge repulsion at the molecular level.  In the case of hard or soft 
ionization, the standard result is an ionic species entering the mass analyzer.  The 
preferred ion sources for GC-MS include EI and chemical ionization (CI).  The 
advancements in the field that led to LC-MS success include significant advancements in 
ESI, which will be discussed in a subsequent section.  The popular ion source for time of 
flight mass analyzers is the matrix-assisted laser desorption ionization (MALDI) source, 
which has performed very well for select microbiological and imaging applications.22,36  
The primary role of the ion source is to deliver ionic species into the mass analyzer in a 
charged state that is reproducible.   
 The type of mass analyzer used for this project is a QqQ detector, a scanning 
instrument.  The principle of a scanning instrument, quadrupole, ion trap, or magnetic 
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sector instrument, is that the electric or magnetic field must be continuously varied to 
obtain spectra.37  For comparison, a TOF instrument is an example of a non-scanning 
analyzer.  Once an ionic species enters the mass analyzer of a scanning instrument, it is 
focused into an ion beam by an electromagnetic field that only allows ions that fit the 
selected m/z ratio to reach the detector.  The mass analyzer is responsible for the 
specificity possible in MS experiments as the detector is not able to distinguish what it is 
detecting.  The mass analyzer’s primary role is to vary the electromagnetic field in such a 
way that only the selected ion can achieve a stable trajectory and successfully reach the 
detector.   
 The detector and computer will simply be described as data collection and instrument 
control/data analysis, respectively.  The detector types vary, but a popular type is electron 
capture detection, which is often coupled with electron multiplier technology, making the 
incident current recorded much greater.  As previously stated, the detector does not 
record the identity of what is hitting it; instead, the mass analyzer directs only specific 
ions towards it, and the detector simply counts hits.  The computer is used to operate the 
instrument and to analyze the data.   One computer capable of controlling both systems, 
LC and MS, in one software platform is the current standard.  The detector and 
computer’s primary roles are to present the data in a meaningful way to the scientist and 
afford ease in operation through automation. 
 The potential of combining an instrument capable of robust and customizable 
separations, paired with a universal detector with high specificity, inspired the creation of 
a series of hyphenated devices.  The most influential of the hyphenated instruments in the 
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clinical laboratory include GC-MS for its early entry and broad applications with small 
molecules, followed by the diverse and influential LC-MS/MS.  A brief review of the 
applications, utility, and limitations of these techniques will be discussed. 
1.5.1.1 GC-MS 
 The use of GC-MS for the highly specific detection of small molecules in body fluids 
became mainstream in the late 1980s after a federal mandate.  The increased utilization of 
GC-MS was a direct response to overcome some of the flaws inherent in immunoassay.39  
The increased specificity and low limits of detection GC-MS could achieve quite 
remarkable for small volatile non-polar molecules that did not suffer from issues of 
thermal instability.22  The preparative chemistry required in extraction and sample 
preparation before the introduction onto the instrument is often cumbersome in GC-MS.  
Many biomolecules and drug metabolites are polar and require sample preparation steps 
such as derivatization to increase volatility or thermal stability for compatibility with  
GC-MS measurement techniques.  The amount of time a scientist must spend preparing 
samples before injection can be a high cost to the laboratories operating budget while also 
requiring the use of harsh chemicals and large solvent volumes.  Despite the time needed 
for adequate sample preparation, the requirement of volatility, and limitations regarding 
some molecules’ thermal stability at high temperatures in helium gas, GC-MS is quite 
useful for some applications. 
 The GC-MS instrument is still a mainstay of the large modern clinical laboratory, 
with a strong history detecting small volatile non-polar analytes that have a high degree 
of thermal stability.  Even with the 30 years of history that GC-MS has in the clinical 
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laboratory, it remains a niche technique that many smaller labs do not have.  The 
challenges that GC-MS poses which inhibit widespread application, include the 
complexity of the instrument, the sparsity of experienced personnel, the lack of 
standardized reagent kits and the specific requirements for the analyte, previously 
discussed.22  While the GC-MS instrument has shown substantial promise as a permanent 
resident of the clinical laboratory, it lacks the diversity of applications and reproducibility 
that LC-MS/MS has been able to achieve.   
1.5.1.2 LC-MS/MS 
 The combination of LC and MS would take critical advancements in instrument 
technology, including the ESI source, the QqQ mass analyzer, and several decades to 
arrive as the premier instrument for separation and quantitation of a wide range of 
analytes.  The significant advantage of LC-MS/MS techniques as compared to GC-MS is 
less restriction on target analytes, which results in less time in sample preparation for the 
scientist.  The decrease in sample preparation time has positive impacts not only for 
budget but also for efficiency and turnaround time from order to result for the provider.  
The LC-MS/MS instrument does not utilize high temperatures to effect separation, as is 
the case for GC-MS, which allows LC-MS/MS to analyze thermally labile ionic species.  
Besides, LC-MS/MS instruments do not require volatility of the analyte, so large 
biomolecules can be assayed, higher than the 600 Dalton cutoff often cited in GC-MS 
literature.37  The time saved in sample preparation is a result of the LC-MS/MS lacking 
the two requirements as mentioned above of volatility and thermal stability, which often 
obviates the need for derivatization.  These fundamental differences in analyte 
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requirements between GC-MS and LC-MS/MS coupled with the vast diversity in column 
chemistries and MP combinations possible with LC-MS/MS have led to a boom in 
diverse applications using an LC-based platform.   
 The significant technological advancements that allowed LC-MS/MS to become a 
trusted application in clinical diagnostics were the ESI source and the QqQ detector.  As 
discussed previously, the ESI source is a soft ionization technique that generates a fine 
mist of charged analytes inside droplets of the MP.  As the droplets evaporate, their radii 
decrease, and the charged species contained within are forced closer together.  At some 
critical point, the ionic species within are forced so closely together due to this gentle 
drying by sheath gas, that the electrostatic repulsion causes the droplet to break apart, 
known as a Coulombic explosion.37  The result of this explosion is that the ionic species 
is charged, in a gaseous state and free from the MP droplet.  Before ESI technology, the 
volume of liquid leaving an LC column, could overwhelm the MS and prevent accurate 
measurement.   
 In addition, changes had to be made to typical LC MPs to be amenable to 
combination with MS.  The high salt concentrations used in many LC-ultra-violet 
detection experiments needed to be adapted to work with MS.  The salt would cause 
substantial dirtying of the ion-optics of the mass spectrometer.  The standard MP 
additives that have been shown to work well in an LC-MS/MS experiment include low 
concentrations of ammonium acetate, ammonium formate, and formic acid.  Ammonium 
acetate and ammonium formate are buffer salts that can stabilize the pH of MP that stay 
on the instrument for several days, and provide a charged adduct for use in an experiment 
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with an ESI source.  Recall that ESI is a soft ionization technique that typically does not 
fragment the molecular ion but can add an adduct mass to it.  Formic acid is used to 
facilitate ionization and is typically added in both A and B MPs at concentrations 
between 0.1-1.0 percent.  The advancements in ion source technology, column variety, 
and understanding of MPs that behave with MS were all significant steps.  However, 
perhaps none of these compare to the creation of the QqQ (Figure 10). 
 
Figure 10.  Triple quadrupole mass analyzer (QqQ).  A photograph of a QqQ from a 
Waters Acquity TQD instrument. 
 
 The QqQ has made the LC-MS/MS assay a reference method for measuring many 
molecules due to its optimal specificity and quantitation accuracy.21,22  To be a reference 
method means that this assay has the profound distinction that all new tests by alternate 
methods be judged against this for accuracy.  The QqQ was invented by Yost in the 
1970s and has grown by leaps and bounds since then.40  The fundamental innovation in a 
QqQ compared to a single quadrupole instrument is that it is composed of two scanning 
mass analyzers in series, separated by a collision cell.  The collision cell is filled with a 
noble gas, often argon, which does not interact chemically, yet provides an obstacle that 
results in collision-induced dissociation of ions as they travel through this cell at high 
speed.  The resulting control of the mass spectrum measured is profound.   
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 The scientist can now select a specific m/z in the first quadrupole, allow a 
fragmentation event to take place, and then select for a specific m/z in the second 
quadrupole, which is known as measuring a transition.  Another option is to select a 
specific m/z in the first quadrupole, allow the fragmentation event to occur, then operate 
in scan mode and collect data on all fragments that pass through the second quadrupole.  
The result is a substantial increase in the specificity of the measurement, which translates 
to a more significant signal to noise ratio and ultimately a lower limit of detection for 
analytes in complex mixtures.21,22,37 
 The typical LC-MS/MS experiment involves multiple degrees of separation, 
extraction, then chromatography, then mass selection, followed by fragmentation and 
mass selection yet again.  The use of hyphenated techniques has profound analytical 
power in that each step is a selective enrichment of the analyte in contrast to the 
background.  The reality that each step in the process does not result in absolute analyte 
recovery but rather a selective increase in analyte over the matrix is essential to realize.  
This process results in an increase in the signal to noise ratio and imposes a challenge for 
quantitation relevant to the initial sample concentration.  This challenge is met with the 
addition of internal standards for accurate quantitation.  Internal standards will be 
discussed in a later section but are used to back-calculate the initial concentration from 
the measured concentration.  The selectivity in each step of the separation is of utmost 
importance due to biological samples’ inherent complexity and diversity.22  There is a 
limit to the amount of hyphenation that is useful, at some point, analyte recovery is so 
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Figure 11.  Selectivity gained by hyphenation.  Hyphenation has a significant impact on 
the signal to noise ratio, up to a certain point.  Adapted with permission from.41 
 
 The loss of analyte in each separation step precludes complete recovery but does 
allow for selective recovery.41  While the selectivity gains increase with each separation 
modality, there is an optimum number of separations.  Excessive separations can inhibit 
the absolute recovery of the analyte, resulting in sensitivity issues for the detector.  The 
ability to back-calculate the initial concentration relies on internal standards, critical to 
LC-MS/MS experiments.  Internal standards are used not only to compensate for 
retention time drift as previously discussed but also to account for possible ion 
suppression and allow for accurate quantitation.41  An internal standard is typically an 
isotopically labeled analog to the analyte being measured, such that it behaves chemically 
similar but is distinguishable by the detector.37  Thinking back to the hyphenation 
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recovery as the analyte and will function as a multiplier to adjust for weak recovery as the 
sample concentration is back-calculated.   
 Ion suppression is a concept that describes competition in the source for ionization 
energy, between the analyte and other unforeseen matrix components.  The result of ion 
suppression is a relative decrease in energy imparted onto the analyte, which can be seen 
as a decrease in the signal measured at the detector.  A common cause of ion suppression 
is phospholipids from plasma membranes eluting simultaneously in the chromatograph as 
the analyte of interest.  Ion suppression can be checked in method development, with a 
specific infusion experiment, however since every patient sample has a unique quality to 
it, the internal standard provides a compensatory factor for these changes in ionization 
efficiency.42 
 The advancements in LC-MS/MS instrumentation and experimental design make it 
the premier combined chromatographic-mass spectrometric technique in the clinical 
laboratory.  The QqQ also has limitations, in that it only measures nominal mass and the 
breadth of chromatographic approaches that have been published are limited, despite 
theoretical potential.  Despite the limitations, the QqQ is still the gold standard for 
quantitation of analytes in complex mixtures.  Its utility will be highlighted in literature 
applications for the quantitation of MMA in subsequent sections. 
1.6.1 MMA in Literature 
 The lack of an FDA approved commercial assay for MMA, does not mean that no 
research groups have successfully developed an assay for this compound.  On the 
contrary, several groups have successfully measured MMA in biological samples by a 
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variety of methods.  MMA and its isomer SA structures pose particular challenges for 
techniques such as immunoassay, which have limitations for small molecules, to begin 
with, and would be plagued by cross-reactivity for this analyte pair.15,21  The polar nature 
of these molecules makes them less volatile, making sample preparation for analysis by 
GC-MS more cumbersome.  However, the low molecular weight makes MMA a 
candidate for GC-MS or GC-FID measurement, as some groups have demonstrated.  
Measurement by LC-MS/MS removes the requirement for volatility, which, in theory, 
can reduce the sample preparation requirements before analysis.  Within LC-MS/MS, 
different research groups have taken varied chromatographic approaches, including the 
standard RP-LC approach and a newer HILIC approach.  The applications, challenges, 
and lessons learned from the work reported in the literature will be discussed. 
1.6.1.1 GC-MS for MMA  
 In the last forty years, several groups have used gas chromatography for separation 
coupled with a flame ionization detector or mass-spectrometric detector to quantify 
MMA.  MMA’s challenge is the hydrophilicity and polarity of the molecule, often 
requiring extensive sample preparation and derivatization for amenability with GC 
separation.  The variety of sample preparation techniques will not be covered 
exhaustively.  However, several techniques will be discussed as a representative, 
including silyl, cyclohexanol, butanol, and chloroformate derivatives, to name a few.18   
 One of the earliest published methods for quantitation of MMA using GC was a 
capillary GC-MS method using N-methyl-N(t-butyldimethylsilyl)trifluoroacetamide to 
form t-butyldimethylsilyl derivatives of MMA.12  The Windelberg group published a 
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derivatization scheme using dithioerythritol as a reductant, with ethanol to deproteinize 
and subsequent extraction with toluene and methylchlorofomate.43  The compounds 
measured by the GC-MS were the N(S)-methoxycarbonyl ethyl ester derivatives of 
MMA, analyzed in selected ion monitoring mode (SIM). The requirements for 
derivatization were not unique to GC-MS detection; GC-FID analysis also required a 
derivatization scheme.  Even though GC-MS adds specificity relative to GC-FID as the 
data has the second dimension of mass spectrum matching, other than merely retention 
time matching, a group has recently attempted to measure MMA with GC-FID.44 
 GC-MS is considered more sensitive and specific than GC-FID, however, when 
coupled with derivatization by trimethylsilyl trifluoroacetamide (TMS), quantitative 
analysis is still possible with FID detection.44  The method that achieved 
chromatographic separation for these TMS derivatives of MMA included a thirty-minute 
gradient and a final elution temperature of 290 degrees Celsius.  While the lengthy 
gradient achieved reproducible results for the organic acid profile, the utility in a clinical 
setting is questionable as turn-around-time is a significant factor.   
 The GC-MS method for MMA that received the most use in a clinical setting was 
created by the Centers for Disease Control with a derivatization protocol involving 
cyclohexanol and subsequent formation of dicyclohexyl esters.45  However, the time for 
sample preparation and length of the chromatographic run prompted the CDC to migrate 
to an LC-MS/MS-based method to replace this aging assay.  The work done by the CDC 
is a good case study for the use of GC-MS for MMA compared to LC-MS/MS’s promise.  
Table 1 below shows some of the advantages of measurement on an LC-MS/MS 
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platform, such as the time saved and related reduction in personnel costs.  The typical 
requirement for MMA measurement by GC-MS is derivatization, which includes the use 
of harsh chemicals and increases sample preparation time.  Many groups have been able 
to develop LC-MS/MS methods that have do not require derivatization.  In addition to the 
reduced sample preparation times for LC-MS/MS, there is also a trend towards shorter 
chromatographic run times, which increases instrument throughput while decreasing turn-
around time. 




1.6.1.2 LC-MS/MS for MMA  
 The utility of LC-MS/MS compared to GC-MS, is obvious when it comes to a small 
polar molecule, such as MMA.  The time saved in chromatography and sample 
preparation allows increased productivity from both the instruments and the scientists, 
making LC-MS/MS the obvious choice for measurement of this molecule and its isomer 
SA.  However, the question of what LC separation mode to use is perhaps less obvious, 
and literature has no shortage of variations in this arena.  In fact, there are more than 
fifteen analytical methods that boast different sample preparation and chromatographic 
approaches by LC-MS/MS.  The mass transitions used to quantitate MMA in multiple 
reaction-monitoring mode are heavily dependent on derivatization reagents and are too 
cumbersome to describe exhaustively.  The breadth of possibilities for transitions in 
multiple reaction monitoring (MRM) mode will only be displayed representatively in 
Table 2, as the main challenge with accurate quantitation of MMA is a chromatographic 
one.  It should be noted in Table 2 that the choice of m/z transitions is influenced by 
derivatization technique, ionization mode, and extraction technique.  This table was 








Table 2.  MMA MS/MS Values from Literature (Reproduced with permission.5) 
 
 MMA’s chromatographic challenge is due to its polar nature and an endogenous 
structural isomer that is highly abundant.  A co-eluting isobar will prohibit accurate 
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quantitation as the two mass spectrums will be indistinguishable, and the concentrations 
will be added together, making separation a requirement for useful measurement.  The 
challenge of separating MMA and SA has been handled differently in various published 
analytical methods.   
 In theory, MMA’s hydrophilicity makes it a poor candidate for RP-LC, yet many 
groups have tried this approach despite this fact.  The reality that RP-LC is the dominant 
separation mode used in clinical laboratories and has the most significant market share of 
commercially available column chemistries often influences this technique’s application, 
despite its shortcomings for polar molecules.18,26,46  The typical RP-LC approach uses a 
C18 column with long carbon chains that are chemically bonded to a silica particle and 
preferentially interact with non-polar molecules, causing retention.  The typical gradient 
parameters include a water-based weak MP followed by a strong eluting MP with a 
higher percentage of strong organic solvents such as methanol or acetonitrile.    
 The purpose of RPLC can simply be described as the selective retention of non-polar 
compounds, which will elute in reverse order of polarity, with the most polar eluting first.  
The polarity of both MMA and SA means that they are both likely to elute early, causing 
issues with the background signal as most non-retained compounds elute early in a 
chromatographic run.  Also, the structural similarity for two poorly retained compounds 
makes separating them by this technique difficult.  For discussion, three distinct methods 
of dealing with this challenge by RP-LC will be compared, two of which involve 
derivatization and one of which does not.   
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 The most straightforward and most direct approach is to skip derivatization and 
analyze the MMA and SA directly, which allows for increased throughput relative to 
methods requiring derivatization.46  While this approach has a theoretical advantage in 
time saved, it is flawed in that it relies on a C18 column to efficiently separate two highly 
polar molecules, which are then measured in MRM mode using identical m/z transitions.  
The obvious issue here is the high likelihood of co-elution, especially as the column ages 
and resolution decreases and the potential consequence of inaccurate quantitation.  The 
theoretical time saved in sample preparation may well be consumed troubleshooting and 
repeating runs when this poor assay design does not function to its ideal capacity.  The 
separation of MMA and SA without derivatization has been shown to achieve baseline 
resolution on an RP-LC column.  However, it is likely to become more problematic as the 
column degrades with repeat injections.  One group showed that every twenty injections, 
a significant column wash, with as many as one hundred column volumes of wash are 
needed to prevent deterioration in peak shape on a C18 column.5 
 The remainder of the approaches for RP-LC method development for MMA all 
involve derivatization.  However, the combinations are extensive and will only be briefly 
described herein.  The approaches for RP-LC with derivatization typically fall into two 
categories, derivatization to improve separation by RP-LC or derivatization that creates a 
unique mass spectrum between the two isomers, SA and MMA.2,7,16,18,47  While most 
approaches use chromatography to separate these two isobars, one group developed an 
interesting approach in which derivatization precluded the need for separation.2  The 
mass spectra of MMA and SA without derivatization are identical, but when butylated the 
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mass spectra are distinct.2  The two compounds are distinguished by a branching ratio 
used to calculate the amount of each isomer.  This approach is an interesting one in that it 
does not rely on the RPLC to separate these two compounds but instead uses the column 
as a simple sample inlet and lets the MS/MS distinguish the two by mass spectrum. 
 The vast majority of derivatization schemes used in literature for MMA detection by 
RP-LC are performed to improve the separation.  The creative ability to use 
derivatization to circumvent the need for separation by LC does not reduce the sample 
preparatory requirements or use LC effectively.  Nevertheless, Kushnir’s approach is 
unique compared to the standard attempts to derivatize to effect a greater separation by 
LC.   As an example, one group reported a chromatographic resolution of greater than ten 
or 0.81 minutes of separation between the isomers MMA and SA in an RP-LC run with 
derivatization.47  This is a promising result, but the length of time required for this 
analysis is eight minutes, and the cost per test is considerably higher with derivatizing 
reagents involved.48   
 The separation of SA and MMA by RP-LC can be aided by derivatization, including 
esterification of the carboxylic acid moieties.  Many techniques exploit the pKa 
difference between SA and MMA with a MP pH around 4-4.5, showing the most efficient 
separation.47  Other groups have tried solid-phase extraction with positive pressure 
devices, which are cumbersome and require additional equipment.18,47  Although there 
have been many groups to publish methods using RP-LC-MS/MS, the requirement for 
derivatization to achieve an accurate and robust separation make this a less than ideal 
solution to the chromatographic challenge posed by these isobars.  RP-LC, although 
 52 
coupled with costly derivatization and laborious sample preparation, it is also trusted and 
widely used due to inertia in the field.48 
 A few enterprising groups are starting to look into orthogonal separation techniques, 
which allow for robust separation without the drawbacks previously mentioned using RP-
LC for polar molecules.  The most widely published of these orthogonal separation 
modes is HILIC, a chromatography form that retains polar compounds by a partition 
mechanism.  The mode of retention in HILIC is particularly well suited for retaining the 
polar MMA and SA, which would elute later in the gradient, with non-polar molecules 
eluting earliest.26,48,49  The increased retention time, results in a more reliable separation 
without the need for derivatization to enhance the interaction with the stationary phase.  
While it may seem common knowledge that utilizing a stationary phase that retains polar 
molecules preferentially will enhance the efficacy of a separation, there were many myths 
in the field regarding the incompatibility of these LC modes with detection by MS.  In 
other words, RP-LC was considered favorable because it is thought to be the most 
compatible with MS detection.  The somewhat misguided concerns with HILIC that 
reinforced this reliance on RP-LC included the excessive column volumes required to re-
equilibrate a HILIC column, the high aqueous content of the MP’s incompatibility with 
an ESI source and the lack of commercially available stationary phases.   
 In some pioneering work on MMA done in 2011, separation of MMA using     
HILIC-MS/MS was shown to be a robust technique with excellent chromatographic 
resolution for MMA, SA and phospholipids.26  This work was a significant step away 
from RP-LC as the only option in the theoretical separation space available to clinical 
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laboratorians.  The publication of this HILIC-MS/MS method for the quantitation of 
MMA successfully debunked several myths.  The work demonstrated a high throughput 
method that did not require excessive re-equilibration time for reproducible 
chromatograph.  It demonstrated the divert valve’s utility for preventing the high aqueous 
content portion of the run from flooding the source.  The final method achieved in this 
pioneering work by Rappold and Grant had a total run time under three minutes and 
reproducible chromatography at ten thousand injections.26  Overall, the work highlighted 
the potential for utilizing non-traditional LC-MS/MS MP to achieve excellent 
chromatographic control for polar molecules.   
 HILIC is not the only orthogonal separation mode available, but it is the most widely 
used based on current literature for MMA.  There was some lack of clarity in the field 
over the distinction between HILIC and ANP.  Some considered the former a subdivision 
the latter, others describing their difference based on retention mechanism and another 
group showing the heterogeneity within this stationary phase class when it comes to 
adsorbed water layers.26,31,35,50  The accumulation of these examples over the last decade 
or so paint a clearer picture; HILIC columns operate on partition mechanism, with the 
thickness of the water layer varying incredibly from column to column.31,35  HILIC 
columns are made with polar functional groups bonded to Type-B silica beads, which 
have silanols (Si-OH) on the surface and encourage the formation of that water layer 
(Figure 7).  Whereas ANP columns are made with Type-C silica beads, which are 
covered in silica hydride moieties preventing the formation of this water layer.50   
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 ANP columns have less than a monolayer of adsorbed water on their surface, which 
supports the adsorption mechanism proposed by the Pesek group.31,35  The work by 
Soukup also demonstrated vast heterogeneity in the thickness of the adsorbed water layer, 
which explains the dramatically different ideal conditions for each column, as found by 
Rappold and Grant in their work with HILIC method development for MMA.26,35  The 
preliminary work has been done to prove orthogonal separation modes to RP-LC have a 
place in the clinical laboratory, but what has yet to be done is a side by side comparison 
of a HILIC and ANP retention mechanism for the quantitation of MMA.  
1.7.1 Research Goals 
 This study aims to perform preliminary experiments that will later guide the method 
development process for a quantitative LC-MS/MS assay for MMA in biological 
samples.  The approach can be broken down into three fundamental sections: (1) to 
develop an MS/MS method for MMA, MMA-d3 and SA*; (2) to develop and optimize 
an LC method; and (3) to compare the separation modes ANP and HILIC for MMA.   
 In this study, MMA, MMA-d3, and SA* were infused directly into the MS/MS, and a 
variety of instrument parameters were adjusted to identify target ions representative of 
each compound.  Once the target ions were found, optimizing tune settings was 
performed to set appropriate temperatures and voltages for maximum response.  In 
addition to identifying stable representative target ions, the aim of the MS method 
development portion of the study included identifying daughter ions and finding the ideal 
ionization mode.  Another aim of the study was to choose optimal resolution settings and 
verify the detector’s  mass accuracy.   
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 The study’s second aim was to develop and optimize an LC separation method across 
three stationary phases to determine the ideal column chemistry and separation mode for 
MMA, MMA-d3, and SA*.  Taking the MS/MS transitions from the first part of the 
study, a preliminary method was developed to experiment with various LC gradients with 
subsequent detection by MS/MS.  The three stationary phase classifications tested 
included RP, ANP, and HILIC.  For each classification, one representative column was 
tested, Phenomenex Kinetex XB-C18, Cogent DH, and Waters Acquity UPLC® BEH 
Amide, respectively.  Optimization of parameters such as flow rate, MP composition, 
concentrations of various mobile phase additives, and the gradient slope was performed 
to improve peak shape, retention time and examine effects to selectivity.  In addition to 
measuring the influence on chromatographic parameters, the various separation modes 
and stationary phases were compared with elution time, mobile phase composition at that 
elution time and effect on the signal generated by the MS/MS.   
 The study’s third aim was to examine if the retention of MMA, MMA-d3, and SA* 
on the Cogent DH column versus the Waters BEH Amide column exhibited an obvious 
ANP versus HILIC retention mechanism.  In order to test this theory, an experiment 
involving salt concentration was performed.  The salt concentration study was performed 
by varying the concentration of buffer salt ammonium acetate from 10 mM to 100 mM 





2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Analytes  
 The analytes were chosen as follows: MMA is the target analyte that predicts the 
pathophysiology, MMA-d3 is an internal standard for aid in quantitation, and to account 
for possible ion suppression, and SA is an endogenous interferant.  However, as 
mentioned previously, 2,2-dimethylsuccinic acid (SA*) was used in place of SA in this 
study due to limitations in availability.  The analytes of interest were obtained from 
Cerilliant, with MMA and MMA-d3 having initial concentrations of 1 mg/mL in 
acetonitrile, whereas SA* was in pure powdered form.  The formula weight for MMA is 
given as 118 g/mol.  The formula weight for MMA-d3 is given as 121 g/mol.  SA*’s 
formula weight is 146, which is different from the actual analyte of interest, which is SA 
with a mol weight of 118 g/mol.  SA* is used as a surrogate for SA but still has utility in 
measuring chromatographic separation effects.  The SA* was prepared by measurement 
on a Denver balance and then dissolved into MeOH to achieve a final concentration of 1 
µg/mL.  For most experiments described below, a concentration of 1 µg/mL in MeOH 
was used for all three analytes of interest.  However, some infusion experiments were 
attempted at concentrations of 500 ng/mL.  The desired concentration was achieved by 
diluting this 1 µg/mL solution in MeOH with an equal part MeOH with 0.2 % formic acid 
to achieve a final concentration of 0.1 % formic acid.  The vendor information can be 
found in Table 3. 
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Table 3.  Analyte Vendor Information 
Name Vendor Catalog Number Lot Number(s) 
Methylmalonic Acid Cerilliant M-080-1ML FN05101902 
FN048181405 
Methylmalonic Acid – d3 Cerilliant M-105 FN09171501 
2,2 dimethylsuccinic acid Sigma Chemical D-3394 54H3673 
 
 The dicarboxylic acid structure of the analytes makes them polar molecules with two 
pKa’s.  The two pKa’s of MMA are at pHs of 3.07 and 5.76, while the pKa’s of SA are at 
pHs of 4.21 and 5.64, both at 25 degrees C.20  While no information is available 
regarding the pKa’s of MMA-d3 they can be assumed to be quite similar to MMA, as the 
only difference is the replacement of three deuterium ions for three hydrogens.  The 
slight difference in pKa’s is a characteristic that can be exploited in separation if carried 
out at a carefully chosen pH.   
 The molecular formula of the analytes can be seen in Table 4. 
Table 4.  Analyte Molecular Formulas 
Name Molecular Formula 
Methylmalonic Acid C4H6O4 
Methylmalonic Acid – d3 C4H3O4D3 
Succinic Acid C4H6O4 
2,2 – dimethylsuccinic Acid  C6H10O4 
 
 As mentioned previously, the ideal analyte to test chromatographic separation for the 
two isomers would have been SA rather than dimethylsuccinic acid (SA*).  However, the 
2,2-dimethylsuccinic acid was procured before the experiment’s initiation and as merely 
an interferant in the assay, not a true analyte of interest; it was decided that the 
procurement of SA was an unnecessary cost.  While there are obvious disadvantages 
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making assumptions about SA’s behavior based on 2,2-dimethylsuccinic acid, it provides 
some information regarding chromatographic control of a succinic acid derivative. 
2.1.2 Mobile Phase Constituents 
 This study’s MP constituents include both aqueous and organic solvents, buffer salts, 
and formic acid.  The MPs were prepared by weighing the buffer salts on the A-250 
analytical balance.  Subsequently, those salts were dissolved in the desired proportions of 
aqueous and organic solvents to achieve the concentration required in that portion of the 
experiment.  All MPs were made with dedicated LC-MS/MS glassware that was cleaned 
with a protocol to prevent detergent contamination or other potential interferants.  The pH 
of select MPs was checked using a Corning 320 pH meter.  All MPs prepared were 
sonicated with a loose cap for ten minutes in a Branson Ultrasonic Cleaner sonicator to 
ensure that they were degassed before loading onto the LC-MS/MS.  All reagents were 
HPLC grade.  The water used in the study was treated by a Millipore Milli-Q water 
system, which produces > 10 mOhm water, which was subsequently polished by a 
Barnstead filtration device to reach a final resistivity of 18.2 mOhm.  The list of MP 
constituents used in this study can be found in Table 5. 
Table 5.  Mobile Phase Constituents 
Name Vendor Lot Number 
18.2 mOhm water Barnstead EasyPure RF - 
Acetonitrile J. T. Baker 0000242659 
Methanol Honeywell DW224-US 
Ethyl Acetate J. T. Baker 0000240898 
Ammonium Acetate Sigma-Aldrich BCBT2624/BCCB9847 
Ammonium Formate Sigma-Aldrich BCCC3106 




 An analytical column is composed of small silica beads packed into stainless-steel 
housing, with frits on either end to contain column’s beads.  The silica beads often have 
various functional groups bound to their surface to affect the desired selectivity for 
specific classes of analytes.  The three columns used for this experiment are each 
representative of a unique chromatographic separation mode.  The C18 column was 
chosen to represent a stationary phase that is amenable to RP separation.  The Cogent DH 
column was chosen to represent a stationary phase that is amenable to ANP separation.  
The Amide BEH column was chosen to represent a stationary phase that is amenable to 
HILIC separation.  The characteristic functional group present on each of these columns 
can be seen in Figure 12 below. 
 
     
 
Figure 12.  Column chemistries for C18 vs. DH vs. Waters Amide BEH.  Representative 
imaged of the surface chemistries for the particles within each column used in the 
experiment.  Phenomenex C18 can be seen on the left, Cogent DH in the center, and 
Waters BEH-Amide column on the right. 
 
 The clinical environment trend is to use smaller internal diameter columns with tiny 
particles, which together decrease solvent usage and maximize surface area for potential 
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contact of the analyte with the functionalized stationary phase.  There is a tradeoff 
between chromatographic resolution and chromatographic run length, where column 
length, flow rate, and back pressure are all factors.  Generally speaking, a shorter column 
will have lower back pressure and higher throughput than a longer column at the same 
flow rate, but chromatographic resolution may be negatively impacted.  Suppose the 
instrument can operate with high back pressure.  In that case, as is the case for a UHPLC 
instrument, a potential solution is to increase the MP flow rate to achieve suitable 
chromatographic resolution within the desired run time.  The column dimensions used in 
this experiment can be seen in Table 6.  It should be noted that the C18 and DH columns 
are the same lengths, but the BEH-Amide column is twice the length.  A longer column 
can offer more theoretical plates, which can translate to better resolution but also longer 
run times or higher back pressures can present challenges as will be discussed later. 
Table 6.  Column Dimensions 
Column Manufacturer Dimensions Particle Size Pore Size 
Kinetex XB-C18 Phenomenex 50 x 2.1 mm 2.6 micron 100 Å 
Diamond Hydride Cogent 50 x 2.1 mm 4 micron 100 Å 
BEH-Amide Waters 100 x 2.1 mm 1.7 micron 130 Å 
 
2.1.4 Miscellaneous Materials 
 In addition to the analytical instrument discussed in the next section, several ancillary 
pieces of laboratory equipment were used in various reagent preparation phases.  The 
equipment list will be exhaustively prepared in Table 7, and a short description of the 
practical usage will follow.  
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Table 7.  Additional Lab Equipment 
Equipment Vendor Function 
Analytical Balance Denver Instrument Co. 
(A-250) 
Weigh MP additives and SA powder 
Lab Grade Water 
Filter 
Millipore Generate >10 mOhm water for 
further filtering 
LC-MS Grade Water 
Filter 
Barnstead Generate >18 mOhm water for MP 
preparation 
Sonicator Branson Ultrasonic 
Cleaner 
Degassing of MP’s 
Laboratory 
Glassware 
Schott To measure and hold MP and stock 
standard solutions 
pH meter Corning 320 To pH MP 
Pipette Eppendorf To spike standards 
  
 The various equipment listed in the table above was used to prepare standards and 
MP as briefly described below.  The analytical balance was used to weigh the 2,2 
dimethyl succinic acid and the buffer salts for the various MPs.  Many of the MPs 
required water, and the process for the preparation of LC-MS grade water involved two 
filtration units, as described in section 2.1.2.  Working standards were made by spiking 
stock standards into an appropriate volumetric flask filled halfway with methanol using a 
hand pipettor of appropriate volume and then filling with methanol up to the line.  The 
pH meter was used to pH the MP used for infusion experiments to predict MMA’s 
ionization state.   
2.2 Instrumentation 
 The LC-MS/MS instrument used in this study was a Waters-Acquity TQD.  The 
instrument is equipped with a sample manager, a binary solvent manager, a column oven, 




Figure 13.  Waters Acquity TQD used in this experiment.  Photo of the instrument all 
experiments were performed on – various modules labeled for clarity. 
 
 The sample manager is in a temperature-controlled environment with an autosampler 
needle capable of serial injections by programming a sample list on the interfaced 
computer.  The autosampler needle draws a volume specified by the method into a 
sample loop attached to a divert valve.  The divert valve then actuates to accept fluid 
from the binary solvent manager, which flushes the sample bolus into PEEK tubing and 
moves towards the analytical column housed inside the column oven.   
 The binary solvent manager has two pumps for each MP (A or B, respectively), 
which drive the high precision fluidics system on board and prevent any turbulence or 
interruptions to flow otherwise possible if the pump was inconsistent.  The binary solvent 
manager delivers an exact MP composition as specified by the operator in the method.  
Column Manager 
Sample Manager 
Binary Solvent  
Manager 
LC Stack 
Mobile Phase Tray  
MS/MS 
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The two A and B side MP pumps to mix the MPs and deliver a constant flow rate to the 
analytical column.  The binary solvent manager also has an online degasser, removing 
small air bubbles to prevent air from getting trapped inside the column.   
 The analytical columns are housed within a temperature-controlled column oven, 
which holds a consistent temperature throughout the analytical run.  This instrument can 
hold four analytical columns, and the operator can easily toggle through the desired 
column for each application as specified in the method.  The sample bolus is separated 
and concentrated into various peaks based on the analytical column’s selectivity in use 
and eluted into a short length of PEEK tubing traveling towards the MS. 
 The PEEK tubing coming from the column oven then feeds into another divert valve, 
which can toggle towards waste or the MS depending on the operator’s specifications in 
method development.  Another potential path to the MS is through an infusion syringe 
that skips the LC and directly feeds into the source for tuning and method development 
experiments.  The path into the MS includes traveling through an ESI probe, which is 
equipped with a capillary needle that is charged and produces a fine spray of mist with 
sample and solvent present.  The sample now in a mist in the gas phase is dried with a 
gentle stream of nitrogen gas supplied as a sheath gas.  The sheath gas helps desolvate the 
analyte while preventing the deposition of particulates on the skimmer cone.  The 
charged analytes then enter into the MS by passing through a charged capillary cone and 
entering what is often referred to as Q0, or the beginning of the ion optics. 
 Inside the MS/MS, the ions are first focused into a beam by applying an 
electromagnetic field.  The two quadrupoles can be operated in several ways, but for the 
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method developed for this study is an MRM method.  In an MRM method, the first 
quadrupole selects for an ion of interest, fragments it in the collision cell by a       
collision-induced dissociation with argon gas.  The fragments can then be selectively 
allowed to pass to the detector by applying another electromagnetic field, which allows 
for an unparalleled level of specificity.  The detector measures the current created by ions 
impacting its surface, and this signal is converted and displayed as a quantitative 
measurement in the MassLynx (v4.1) software package.   
 The operator can perform various functions inside the MassLynx software, including 
but not limited to peak review, signal to noise quantitation, calibration, and quantitation 
of analytes.  MassLynx was used to develop the various versions of methods that were 
used, and sample lists were created to serially inject through a range of conditions, with 
subsequent data review being performed in MassLynx as well. 
2.3 Methods 
2.3.1 Development of an MS/MS method for MMA, MMA-d3, and SA*  
 The identification of target ions, fragment ions, and the appropriate MS acquisition 
parameters was obtained by a series of experiments involving the direct infusion of pure 
standards into the MS.  The infusion was performed in two ways: a direct infusion and a 
combined infusion, which involved the standard being infused blending with the LC 
eluent in the ESI source.  The flow rate for the infusion syringe delivering the 
compounds, MMA, MMA-d3, and SA*, was 10-20 µL/min, regardless of combined or 
direct infusion.  The MP used for combined infusion was composed of 85 percent 
acetonitrile and 15 percent water, with 100 mM ammonium acetate and one percent 
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formic acid at a flow rate of 800 µL/min.  In addition to observation for expected target 
ions related to the analyte, based on the compound’s formula weight and the ionization 
mode used, the span was increased to observe potential contaminants and see if there 
were any unexpected in source fragmentation taking place.  Adjusting the span 
essentially alters the amount of the mass spectrum visible to the operator allowing one to 
zoom in or observe a more significant portion of the m/z range. 
 A typical infusion set-up can be seen in Figure 14. 
 
Figure 14.  Infusion set-up.  An image from Waters MassLynx software showing a live 
feed of the infusion set-up. 
 
2.3.1.1 Identification of Precursor Ions 
 Two approaches were taken while infusing the compounds, to identify precursor ions 
for the target analytes.  Waters MassLynx software comes equipped with a program 
called Intellistart, an automated optimization program that varies the MS acquisition 
parameters if a specific precursor ion is specified.  In theory, Intellistart should return 
fragment ions and all relevant tune parameters that are needed to optimize signal 
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response.  The utility of this program will be discussed further in the Results section, 
however in short, it was not entirely useful as the results obtained varied considerably 
each time it was performed, and it often returned precursor and fragment ions that did not 
make sense.   
 The method that did work to identify precursor ions was a direct infusion combined 
with manual tuning.  The initial concentration of analyte infused was 500 ng/mL in 
methanol.  However, due to the presence of some contamination in the sample reservoirs 
feeding into the ESI source, the background was substantial at these concentrations.  The 
concentration of analyte that resulted in a successful infusion experiment was 1 µg/mL in 
methanol.  The basic procedure involved modifying various MS tune parameters while 
constantly infusing the analyte of interest and observing the effect on the response, with 
the maximization of the response being the goal.  The optimized parameters included 
capillary voltage, cone voltage, collision energy, MS1, and 2 resolution and ionization 
mode.   
 The process to identify precursor ions included turning the collision gas off, and the 
collision energy was set to zero.  The capillary voltage was then incrementally increased 
from zero up towards the maximum, and the maxima in response for the analyte signal 
was determined at a specific capillary voltage.  The capillary voltage was then held 
constant at the voltage resulting in the signal maxima, and the cone voltage was 
optimized in the same fashion.  These optimization experiments were carried out in both 
ionization modes, ESI positive and ESI negative modes.  The two ionization modes were 
compared for optimal signal height for the analyte and compared the background 
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spectrum’s noise.  The ionization efficiency was superior in ESI negative mode, and the 
background mass spectra had significantly fewer interferants, perhaps due to a 
contamination issue, as will be discussed in the Results section.  The choice to use unit 
resolution, versus low resolution, versus quantitative resolution was made empirically 
based on the maximum signal obtained in any of the three settings.  The implications of 
this will be discussed in the Results section.   
2.3.1.2 Identification of Fragment Ions 
 Once the correct precursor ions were detected, and their signal strength optimized, the 
iterative process was repeated for the fragment ions.  As may be expected, the fragments 
produced and those fragments’ intensity will be highly dependent on the tune parameters, 
namely collision energy and cone voltage.  The process for manually tuning for 
fragments is analogous to precursors’ process, except that collision gas is turned on.  The 
MassLynx software allows the separate quadrupoles MS1 and MS2 to be operated in 
either a scanning or selective mode.  In order to scan for fragment ions, the MS1 was set 
to allow only the precursor ion of interest to pass through, and the MS2 was left in a 
scanning mode where it would record the m/z of all fragments generated by this precursor 
ion.   
 Once a stable fragment was observed, the span was then reduced to focus on the 
specific fragment ion.  Optimization of the MS acquisition parameters were performed to 
optimize the signal for this transition.  A transition is defined as a precursor ion paired 
with a fragment ion in an MS/MS experiment.  The first quadrupole selects for the 
precursor only, and the second quadrupole selects for only the fragment ion of interest.  
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Generating one signal from the transit of this ion from MS1 through the collision-induced 
dissociation in the collision cell and selecting only one of the fragment ions in MS2.  The 
general scheme for the measurement of an MRM transition can be seen in Figure 15. 
 
Figure 15.  QqQ fragmentation schema.  Photo of a QqQ from a Waters Acquity TQD, 
with sections labeled on the right. 
 
 Once stable transitions were found for each analyte, the optimal collision energy and 
cone voltage were recorded by manually increasing each parameter to observe a signal 
maximum for the fragment.  Once the optimal cone voltage and collision energies were 
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for each transition pair, and the cone voltage and collision energy used for that transition.  
In addition to this MS method, the MS tune page settings were defined based on this 
experiment, including source temperature, the flow rate for desolvation gas, the capillary 
voltage of the ESI probe, ionization mode, and resolution settings.  With the preliminary 
MS method created the next iteration of the method development process involved 
creating an LC method.  The LC method needed to deliver the analyte to the MS in an 
appropriate MP mixture and desired selectivity to allow separation from potential 
interferants. 
2.3.2 Development of an LC Method for MMA, MMA-d3, and SA 
 The process for the development of an LC method for the target analytes was a 
process of trial and error using literature approaches to inform study design.  The fact that 
the analytes are all polar guided the design and allowed specific approaches to be ruled 
out quickly.  The MS portion of the method needs to be built first to enable the 
compound’s detection as it elutes from the column.  If the experiment were attempted in 
reverse fashion, there would be no way to judge what chromatographic parameters made 
positive impacts on the MS signal, as the detector would not know what to measure.  
With the MS parameters set and the MS method built, the LC optimization process began 
with MP selection. In this experiment, the stationary phases being tested include multiple 
column chemistry that span separation modes distinctly different, from RP to ANP and 
HILIC.   
 Initial experiments involved defining a preliminary gradient, experimenting with MP, 
and other chromatographic variables.  Specifically, substituting various MP combinations 
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in the A and B portions of the gradient, optimizing flow rate, and attempting different 
concentrations of MP additives were all initial experiments.  Different column 
temperatures, the gradient slope and re-equilibration time were all varied to achieve 
reproducible chromatography.  The variables observed to choose the ideal LC parameters 
included improvements to peak shape, resolution, effect on retention time, and selectivity 
for the various analytes.  As will be discussed further in the Results section, this trial and 
error approach took many iterations before a baseline chromatographic peak on each 
stationary phase was observed.  The decision to favor a chromatographic mode or MP 
composition was based on the empirically observed response in the MS and the impact on 
the chromatographic variables previously discussed.   
 There was no implicit idea of a specific combination that should work and an attempt 
to force the results towards that preconceived notion.  Instead, each iteration’s results 
were considered, changes to the LC method were made, and successive iterations were 
performed with an unbiased empirical approach to method development that would let 
the data decide the ideal approach.  It should be noted that the column temperatures, 
gradient profiles, MP composition, and flow rates were held constant and compared 
across all three columns before changes were made.  This approach intended to determine 
a baseline chromatographic peak on each stationary phase and then determine if changes 
made to any one of the tested variables had a positive or negative effect on the 
chromatographic peak and MS response. 
 Due to the number of variables being tested, the path to success was not linear.  A 
result of the various chromatographic modes that were attempted caused numerous 
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failures before success was attained.  The various attempts will be discussed in the 
Results section, and some lessons learned that would inform subsequent method 
development attempts.  It should be mentioned that the optimization of LC parameters is 
an iterative process.  While early iterations have provided valuable information, there is 
still room for much improvement.  This portion of the study will continue, as described in 
the Future Work section of this paper. 
2.3.3 Comparing Retention Modes of ANP and HILIC 
 This study’s primary purpose is to produce a viable clinical method for the 
quantitative measurement of MMA.  This study’s secondary purpose is to observe the 
differences in retention mechanism between ANP and HILIC separation modes.  Two 
column chemistries were exposed to the same LC conditions for these experiments and 
the resulting RT trends observed.  The column chemistries tested were DH, the 
representative for ANP, and Amide BEH as the representative for HILIC.  To further 
understand the difference in retention mechanism, a buffer salt experiment was 
undertaken.  The first experiment involved varying the salt concentration in the MP from 
10 – 100 mM ammonium acetate and observing the effects on retention time across two 
stationary phases.  All other LC variables were held constant.  The initial experiments 
described above enabled observation of a baseline peak for each stationary phase, with 
mostly reproducible retention time.  By altering the experimental variable, the salt 
concentration in the MP, the effect on retention time could be measured and correlated 
with an ANP or HILIC retention mechanism.   
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 The theory of ANP-LC would suggest that lower salt concentrations would result in 
longer retention times, whereas the HILIC retention mechanism displays the opposite 
trend.  Therefore, while both ANP and HILIC can retain polar molecules, ANP does so 
most effectively at low salt concentrations, while HILIC is most retentive at high salt 
concentrations.  The purpose of varying salt concentration in the MP on the DH column 


















3.  RESULTS AND DISCUSSION 
3.1 Development of an MS/MS Method for MMA, MMA-d3, and SA* 
 The infusion experiments were successfully generated a preliminary MS/MS method, 
but it took several iterations and some troubleshooting to arrive at this endpoint.  Progress 
depended on overcoming two significant challenges, including contamination of the 
infusion inlet with sodium adducts and low-end mass accuracy in the ESI negative mode.  
Besides, approaches using the software feature Intellistart, part of the MassLynx 
program, were inconsistent and needed to be verified both in the literature and through 
manual tuning experiments.  However, many of these issues were not immediately 
apparent and required countless repeats and deliberation before solving one issue only to 
move onto the next.  Despite these challenges, eventually, all were overcome, and a 
successful MS/MS method was developed utilizing a combination of Intellistart and 
manual tuning while utilizing a combined infusion setting.  Before describing the process 
and various attempts to troubleshoot these issues, the final MS/MS method and tune 
settings can be seen in Tables 8 and 9. 
Table 8.  ESI Negative Mode – MS/MS Preliminary Method 
Compound 
Name 
Parent (m/z) Daughter 
(m/z) 
Dwell (s) Cone (V) Collision 
(V) 
MMA 117 55 0.050 17 17 
MMA 117 73 0.050 17 8 
MMA-d3 120 58 0.050 17 9 
MMA-d3 120 76 0.050 17 9 
SA* 145 83 0.050 30 17 




Table 9.  MS/MS Tune Parameters 
Source (ES-) Analyzer 
Capillary (kV) 2.80 LM 1 Resolution 10.54 
Cone (V) 17.00 HM 1 Resolution 15.00 
Extractor (V) 3.00 Ion Energy 1 0.33 
RF (V) 0.10 MSMS Mode 
Collision Energy 
20.00 
Source Temp. (ºC) 150 LM 2 Resolution 11.31 
Desolvation Temp. (ºC) 250 HM 2 Resolution 15.00 
Desolvation Gas Flow (L/Hr) 500 Ion Energy 2 1.84 
Collision Gas Flow (mL/Min) 0.10 Gain 1.00 
 
3.1.1 Contamination of the Infusion Inlet  
 The Waters Acquity TQD used in this experiment is typically used for a clinical assay 
set up to detect compounds around one kilodalton in mass using ESI positive ionization 
mode.  Historically, the MS/MS portion of the instrument was calibrated for mass 
accuracy annually with NaCsI solution, which has a series of monoisotopic peaks through 
the entire mass range and is well suited as a calibrant for ESI positive mode, especially in 
the mid to high mass range.  Waters Corporation uses this calibrant as their standard 
tuning solution to calibrate LC-MS/MS instruments.51  A typical calibration of the mass 
accuracy is performed by loading a tuning solution onto the front inlet of the MS/MS, 
drawn up into an infusion syringe, and infused directly into the MS (Figure 16).   
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Figure 16.  Front inlet infusion set-up for this instrument.  Photo of a modified Infusion 
inlet on the Waters Acquity TQD instrument used. 
 
 The proper cleaning procedure for the inlet after using a solution like this would 
involve a 50:50 MeOH:H2O mixture.   This mixture should be run through a purge cycle, 
in which the infusion syringe draws up several volumes of solution and then delivers it to 
waste.  However, the instrument used in this study was not typically used for method 
development, nor was the front inlet touched for any reason.  It should also be noted that 
the front inlet had been rebuilt and is not the typical stainless-steel reservoir tubing on 
both sides, but one side has plastic tubing, as can be seen in Figure 16.  
 Leaving a salt solution such as NaCsI in a reservoir that was in contact with the front 
inlet led to contamination with Na+ adducts.  The contamination with sodium adducts 
caused issues with Intellistart, as the software works in such a way that it locates the most 
abundant signal, and in the case of a high amount of sodium adducts eluting this signal 
was often positive.  The Intellistart program saw a high positive signal.  While running its 
optimization script, it would choose ESI + mode as the preferred ionization mode and 
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return different masses each time it was run.  The results did not make sense, but this was 
not instantly recognized as a contamination issue.  The initial theory was that it was a 
software issue, as several error messages appeared at different points of running the 
script.  One error message observed repeatedly can be seen in Figure 17. 
 
 
Figure 17.  Intellistart recurring error message.  Every time Intellistart was used during 
method development, this error would present. 
 
 While the error message seems straightforward, stating that there is an incompatibility 
between a tune file and a calibration file, it was impossible to rectify.  The fact is that no 
combination of tune files and calibration files could make this error message go away.  
Even a tune file that is appropriately linked to a calibration set for the same MS 
resolution and double-checked before did not clear the error message.  This inconsistency 
led to many hours reading forums, contacting Water’s phone support, and e-mails with 
different service engineers until, it was ultimately discovered to be a common fault of this 
aging software version.  According to a service engineer, this message will display to 
alert the operator that the resolution settings for the MS calibration and tune file must 
match, not that they do not match.  While this is not what the wording seems to say, it 
was proven to be the case.   
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 Great care was taken to test this theory, selecting the proper MS calibration file, and 
making sure that the file was linked with the desired tune page.  Using Intellistart set up, 
care was taken to specify the resolution desired, as “Unit Resolution,” which needed to 
match the calibration file’s resolution.  Finally, utilizing the proper resolution settings 
paired to the proper calibration, which was linked with the matching tune page, yet the 
message persisted.  Ultimately, a final attempt was made to generate a new tune page via 
Intellistart, based on the calibration, paired with the correct resolution settings for the 
MS/MS.  This message persisted.  Despite the confusion, this message caused it was not 
the reason for the confusing data being delivered. 
 Fortunately, software error was proven not to be the underlying issue affecting the 
observed inconsistencies in transitions found via Intellistart, however spurious results 
were still observed. Each time the program was run, a different target mass, and a 
different fragment ion were obtained and even a different ideal ionization mode for the 
same analyte.  Once it was determined that the MassLynx Intellistart Software was 
working more or less as expected, despite some limitations based on a small number of 
bugs and the way the optimization script is written, the contamination issue was more 
clearly visible.  If it is not software, it must be hardware, and based on the mode of use 
for front inlets and state of the equipment; it suggested contamination.  To rectify this 
contamination issue, a 1:1 MeOH:H2O mixture was flushed through the front inlets on a 
purge cycle several times, with subsequent purge and refills of the compound to be 
measured.  This approach did much more than methanol only purges to clear the inlet 
reservoirs.  The cleaning’s eventual outcome was that consistent results could be obtained 
 78 
from both reservoirs, but the results were not at the expected m/z for the [M-H]- ions in 
ESI negative mode. 
 3.1.2 Low-End Mass Accuracy Issue in ESI Negative Mode 
 Once the contamination issue and some of the software hurdles were overcome, 
manual tuning experiments were top priority.  The analyte of interest was infused, as 
described above, at a concentration of 1 µg/mL in MeOH.  MMA’s molecular weight is 
118.09 Daltons when infused at 1 µg/mL in electrospray negative mode; it should yield a 
strong [M-H]- ion at 117 m/z.  This experiment was attempted several times using 
Intellistart and again via manual infusion, but there was no signal present at 117 m/z.  
The same experiment was repeated for MMA-d3, the deuterated internal standard, at the 
same concentration of 1 µg/mL in MeOH.  Once again, both manual tuning and 
Intellistart were attempted for this compound, using the ESI negative mode.  The choice 
to use ESI negative for these compounds was based on literature findings, preliminary 
infusion experiments, and carboxylic acid propensity to deprotonate in an ESI source.  
The expected [M-H]- ion for MMA-d3 should have yielded a strong signal at 120 m/z, yet 
once again, this was not the outcome (Figure 18). 
 
Figure 18.  Intellistart readout highlighting issue with mass accuracy.  Data obtained 
from an Intellistart experiment showing a mass shift of 1 Dalton. 
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 By infusing and manually tuning for the compounds and attempting Intellistart, the 
unsatisfactory results could not be blamed on the Intellistart software.  It should be noted 
that the correct formula mass in the chart above is the one given in the last row, 121.  The 
only reason the formula/mass of 120 was given was to assess if the software expected a 
value with the [M-H]- ion already calculated.  However, it was found that this was not 
necessary, and in subsequent experiments, the correct formula/mass was entered.  The 
expected parent m/z in negative ion mode for MMA-d3 is 120 m/z, not the 119 m/z 
shown above; this is due to the mechanism by which ESI ionizes.  To aid in 
understanding a brief review of expected ionization patterns in ESI positive and negative 
modes will be discussed.   
 In positive ESI, a neutral ion can be protonated, forming an [M+H]+ ion, or it is 
possible another cation can be attached, resulting in an adduct ion formation, such as 
[M+Na]+.37  In negative ESI, the converse occurs, with anion attachment or deprotonation 
commonly occurring.  If a molecule has a carboxylic acid, which in the case of this study, 
all analytes studied have two carboxylic acids, a common loss is a proton, resulting in a 
[M-H]- ion.  It is also possible that an anion can be attached, such as [M+CH3COO]- ion, 
which would be an adduct from an acetate ion.  The typical mass spectra that ESI 
generates is dominated by molecular species, as it is a soft ionization technique.  The 
exact process of ion formation in ESI is debated.  However, it is believed to be based 
solely on an analyte’s likelihood to ionize in solution once a voltage has been applied.   
 There is a known preference in ESI to overrepresent the most polar analytes in terms 
of response, due to the increased propensity to ionize.  However, when coupled with LC, 
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which often separates compounds based on polarity, this issue is less pronounced as the 
peaks eluting off the column will be delivered one at a time to the source reducing the   
in-source competition described above.  In summary, the expected ion generated in ESI 
negative mode for a compound with a carboxylic acid, such as MMA, is a [M-H]- ion, 
given the nominal molecular weight of 118, is an [M-H]- ion with 117 m/z.  The expected 
ions for the other analytes in ESI negative mode are also [M-H]- ions, due to the 
carboxylic acids present, with ions of 120 m/z for MMA-d3 and 145 m/z for SA*.  
 The expected masses described above were not the observed masses in any infusion 
experiments, whether using Intellistart or manually tuning.  The initial issue of sodium 
adduct contamination skewing Intellistart results to ESI positive mode, coupled with the 
software glitches observed using Intellistart, caused much repeating and rethinking of 
these initial MS/MS experiments.  Comparing the expected theoretical results with 
literature findings, it was apparent there was an issue with mass accuracy.26 
 The real issue was more subtle and took the investigation of the instrument’s 
historical use and previous preventative maintenance service logs from the manufacturer.  
Upon reviewing these logs, it was discovered that since the instrument was typically used 
in ESI positive mode, all historic mass calibrations had been performed in ESI positive 
mode exclusively.  The calibration of mass accuracy with NaCsI in ESI positive mode 
was sufficient for current instrument applications.  However, it did not provide adequate 
resolution for the low mass range in ESI negative mode.  The infusion of a phosphoric 
acid solution was used to check the mass accuracy.  An eventual recalibration of the mass 
scale in ESI negative mode with phosphoric acid was performed to correct the 
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inaccuracy.  The phosphoric acid calibration solution is an ideal tuning and calibration 
solution for the low mass range in ESI negative mode, with a monoisotopic ion at 99 m/z.  
Once the instrument had been re-calibrated in ESI negative mode with the phosphoric 
acid calibrant, the mass accuracy issue was corrected, and the tuning experiments 
progressed.  The calibration with phosphoric acid in negative mode can be seen in Figure 
19. 
 
Figure 19.  Calibration with phosphoric acid in ESI negative mode.  A series of 
monoisotopic peaks in a phosphoric acid solution is used to set the mass accuracy in ESI 
negative mode. 
 
 After successfully calibrating the MS/MS’s mass accuracy, the infusion experiments 
generated the expected [M-H]- ions, which allowed Intellistart experiments supplemented 
with manual tuning to be performed.  The correction of the underlying mass accuracy and 
contamination issues, combined with forcing Intellistart only to use the negative ESI 
mode, allowed useful data to be obtained from Intellistart.   
3.1.3 Path to a Successful MS/MS Method 
 Intellistart was used as a starting point, but the transitions found were often 
incomplete, and subsequent manual tuning experiments were performed to supplement.  
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An example of an Intellistart transition found, and one missed can be seen in MMA’s 
case (Figure 20).   
 
Figure 20.  MMA Intellistart readout after MS/MS calibration.  Incomplete data obtained 
from Intellistart; however, mass accuracy has been corrected. 
 
 The Intellistart software did return the correct parent m/z after calibration of mass 
accuracy with phosphoric acid.  However, it only found one transition.  Upon further 
review of the report generated by this software program, it had obviously missed another 




Figure 21.  Intellistart report with only one stable transition.  Data from an Intellistart 
report, states only one stable transition, while two are clearly visible and later verified. 
 
 While the Intellistart program returned a finding of only one stable transition, there is 
clearly a second fragment at 73 m/z, which was missed by this software (Figure 21).  
Manual tuning experiments were performed to investigate this second potential transition, 
where MMA was directly infused with the collision gas turned off, and MS1 was set to 
select for 117 m/z.  Once MS1 had a stable signal at 117 m/z, all tuning parameters were 




Figure 22.  Manual tuning and optimization of [M-H]- ion for MMA.  Data obtained 
from a manual tuning experiment while infusing MMA in ESI negative mode. 
 
 The manual tuning optimization experiments were accomplished by infusing the 
compound at 1 µg/mL concentrations in MeOH at a flow rate of 20 µL/min, with a 
combined infusion setting that delivered a constant flow of the MP at 800 µL/min.  The 
MP composition for this experiment was eighty-five percent acetonitrile, fifteen percent 
LC-MS/MS grade water with 100 mM ammonium acetate and one percent formic acid, as 
specified in the methods, and modified from a successful approach in the literature.26  
The cone was cleaned daily during infusion experiments due to the high salt 
concentration of the MP and constant infusion at a high flow rate.   The results of the 
successful tuning experiments can be seen in Table 9 in section 3.1.1. 
 Once the ideal MS acquisition parameters were established for the parent ion and the 
collision gas was turned on.  The collision energy was set to zero and slowly ramped 
upward, and the effect on the fragment ion was observed.  In this manual tuning 
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experiment, the first quadrupole, MS1, was set to select for only the 117 m/z fragment, 
and a daughter scan was performed with a small span centered on the expected fragment 
ion at 73 m/z (Figure 23).  
 
Figure 23.  Manual tuning of fragment at 73 m/z.  Data obtained from a direct infusion 
experiment in ESI – mode with collision gas turned on. 
 
 A daughter scan is where MS1 is restricted to a certain mass, but MS2 is open to 
record all fragment masses.  As the collision energy is ramped from zero upwards, the 
abundance of the parent ion decreases, and the fragment abundance increases, but only to 
a certain point.  As the collision energy is ramped higher, eventually, the abundance of 
the desired fragment decreases.  The most abundant fragment would often shift to a lower 
m/z due to the increased fragmentation.  The goal of manual tuning is to find the optima 
in the curve and utilize that setting to then ramp and optimize the other settings.  This 
process is an iterative one and can produce odd results if only approached in linearly.  For 
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example, if the collision energy were ramped up to 100 eV, the maximum on the scale, 
the only fragments visible are low mass fragments.  Any further optimization done to 
other parameters would not change this fact.   
 A successful approach is to establish a maximum, utilize that setting, then after 
establishing other settings, come back and re-ramp the initial parameter to make sure 
subsequent choices or prior settings on the first iteration do not bias the results.  This 
iterative process affords a better opportunity of finding a global maximum rather than a 
local maximum.  In addition to collision energy, the manual tuning process was 
performed to optimize cone voltage.  The findings from these experiments were used to 
determine the preliminary MS/MS method shown in Table 8 in section 3.1.1.  The mass 
calibration setting chosen to link with the tune page was “Unit Resolution,” which 
offered increased signal strength while maintaining good selectivity. 
 In summary, the MS/MS method development of this process proved to be much 
more involved than previously anticipated.  The number of hurdles that needed to be 
overcome and the disparity of the early results obtained resulted in several prime 
opportunities for troubleshooting.  Unfortunately, the inability to establish an MS/MS 
method with ease led to significant delays in LC method development.  The MS/MS 
method is a requirement before any of the LC work could begin because a detector is 
needed to measure analytes eluting from the column.  Without a properly functioning 
detector, there is no way to record the peaks or observe chromatographic differences 
between the stationary phases.  In the end, the solutions arrived at seem quite obvious, 
but during the process, this was not the case.  Ultimately, the lessons learned are 
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fundamental laboratory concepts, measurements are only as good as the condition of the 
instrument; cleanliness, regular maintenance, and a recent mass calibration are all 
necessities before beginning any method development process. 
3.2 Development of an LC Method for MMA, MMA-d3, and SA* 
 The LC portion of the LC-MS/MS method development was challenging for many 
reasons, but several insights can be gleaned from the preliminary experiments performed.  
Some of the challenges included working with three stationary phases, all representing a 
distinct chromatographic mode, RP, ANP, and HILIC, respectively.  Inexperience in 
method development, combined with atypical solvent selection and high salt 
concentrations, led to high back pressures, which caused a few instrument issues – 
including column leaks, many experiences cleaning the skimmer cone, and the ESI 
capillary probe rebuild.  Other than the troubleshooting experience, the significant 
insights gained can be summarized in three sections: (1) preliminary RT and peak shape 
across the various columns, (2) effects of priming and trends with repeat injections, and 
(3) selectivity and resolution differences across the three columns tested.  Several other 
topics will be touched upon, including points sampled in a given peak, peak symmetry, 
and carryover.  Ultimately, it will be shown that while all three stationary phases can 
separate the analytes of interest, reproducibility and peak shape vary widely.  While 
much work remains for a polished method, DH appears to be a good candidate for further 




3.2.1 Preliminary RT and Peak Shape 
 The initial experiments were performed by injecting each compound one at a time at a 
concentration of 1 microgram/mL on each column using the preliminary gradient shown 
in Table 10. 
Table 10.  Preliminary Gradient 
 Time (min) Flow (mL/min) %A %B Curve* 
1 Initial 0.750 100 0 Initial 
2 0.10 0.750 100 0 1 
3 2.00 0.750 50 50 6 
4 2.25 0.750 0 100 1 
5 3.00 0.750 100 0 6 
6 4.00 0.750 100 0 6 
*Curve values: 1 = Pre-Step, 6 = Linear Gradient 
 
 The other parameters used were a column temperature of 40° C, a 10-microliter 
injection using a 50-microliter sample-loop, and the sample manager temperature was 
held at 10° C.  The MPs used for these successful initial experiments were, ethyl acetate 
for MP A, and a mixture of 80:20 acetonitrile:water with 100 mM ammonium acetate and 
1.0 % formic acid.  The decision to use ethyl acetate as a loading or weak MP was due to 
its miscibility with water and acetonitrile, weak polarity and success in related 
literature.26  The polarity scale for the MPs used can be ranked in terms of relative 
polarity as, ethyl acetate 0.228, acetonitrile 0.460 and water 1.000.52  Attempts were 
made using typical RP solvents.  However, the water-based loading MP’s polarity caused 
elution within the void volume on C18, as would be expected. 
 Trials using a more traditional RP-LC based MP mixture with a water-based MP (A) 
and an acetonitrile-based MP (B) with the same preliminary gradient described above in 
Table 10.  While this MP combination resulted in decreased back pressure and more 
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reproducible retention times (Figure 24), the peak shape was quite poor across the five 
injections, and the analytes co-eluted (Figure 25).    
  
Figure 24.  Stable RT on DH - 5 Injections.  Repeat injections with RP MP mixture.  
Total Ion Chromatograms (TICs) displayed with time in minutes on the x-axis.  MMA,      
MMA-d3, and SA* all present. 
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Figure 25.  DH - one Injection by transition.  One of the TIC’s shown above in Figure 24 
is displayed by m/z transition.  Note analyte co-elution and poor peak shape.  The time on 
the x-axis is listed in minutes.  
 
 The peak shape, early elution, and co-elution problems for this RP-LC MP mixture on 
DH highlighted some issues using water as a loading MP for analytes of this polarity 
(Figure 24).   In addition to the issue with co-elution of SA* and MMA on DH when 
water-based weak MP was used, there were significant issues with back pressure while 
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attempting to equilibrate the Waters BEH-Amide column.  In fact, the Waters BEH-
Amide column could not accommodate 100 % water at a flow rate of 0.750 mL/min 
without back pressures approaching 15,000 PSI, so the method would have to be adapted 
even to get preliminary injections accomplished.  The BEH-Amide column is twice the 
length it is expected that a slightly higher back pressure is warranted, however, attempts 
were not made to extend the run time and decrease the flow rate as it would not serve a 
very fair method comparison.   
 Another MP mixture that was attempted to separate all three analytes on the DH 
column was a more traditional HILIC/ANP water and acetonitrile combination.  As with 
the injections in Figures 24 and 25, the injections displayed in Figure 26 were performed 




Figure 26.  Classical HILIC/ANP MP mixture on DH.  3 injections plus transitions.  The 
MP composition for the data shown is 80:20 acetonitrile:water loading MP, with a 50:50 
acetonitrile:water, strong MP.  In both MP, the additive concentrations are held constant 
at 10 mM ammonium acetate with 0.1% formic acid.  The x-axis shows time in minutes.  
1-3 are TIC’s representative of repeat injections.  Arrows highlight compounds used. 
 
 The three-injection series using this typical HILIC/ANP MP mix demonstrated 
reproducible RT’s as displayed in the bottom three panes of Figure 26.  Relatedly the 
back pressures were significantly less with this mixture, and much less priming was 
required to achieve this stability.  However, the analytes all co-eluted as can be seen in 
the top three panes of Figure 26, which are the individual m/z transitions for the third 




eluted very early, even before the gradient began.  These results suggested that a water-
based loading MP, even if only 20%, would cause the compounds to elute early and 
together.  In fact, the often used HILIC/ANP MP with 80:20 acetonitrile:water worked 
more like an elution MP for these compounds.  Due to these challenges and the success in 
the literature using the non-traditional MP mixture, the decision to try ethyl acetate as a 
loading MP resulted in some promising chromatography. 
 Ethyl acetate, as a loading MP, instantly showed improvements in peak shape and 
separation of SA* and MMA.  Despite the promise of ethyl acetate,  there were 
miscibility issues, which will be discussed.  The preliminary LC gradient and non-
traditional MP conditions described above resulted in retention on all three columns, as 










Figure 27.  MMA-d3 preliminary injections. (A) DH  (B) C18  (C) BEH.  One 
compound (MMA-d3) injected across three columns, with the same gradient and MP 
mixture used.  The x-axis has the time listed in minutes. 
 
 The peak shapes above show distinct differences in width, skew, and absolute 
retention time (Figure 27).  It should be noted that although the column chemistries 
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represent distinct chromatographic modes, the same gradient, flow rate, and MP 
composition were used across all three for comparison.  Though not visible in these 
graphs, the same concentration of analyte was injected, 1 µg/mL, and relatively the same 
response was achieved at the detector, roughly 5e4.  Using the dwell times listed in Table 
8, the peak widths at half height and an MS delay of 5 milliseconds, the sampling points 
per peak are greater than 20 for all three peaks, so sufficient time is available to acquire 
useful MS/MS data for all six transitions.   
 The sharpest and most gaussian peak is obviously the one eluting from the DH 
column at 2.86 minutes, with a peak width of just under 8 seconds and almost no skew 
(Figure 27A).  The peak eluting off of the C18 column was the least retained, with an RT 
of 1.79 minutes, a peak width of almost 10 seconds, and a clear shoulder on the right side 
about halfway down (Figure 27B).  The peak eluting off the BEH amide column has 
many issues, both fronting, and tailing, and peak width of nearly 26 seconds (Figure 
27C).  These initial results were suggestive that DH was an excellent choice of stationary 
phase for a polar molecule like MMA.  Of course, there was still much room for 
improvement in peak shape and response, but reproducibility had to be addressed first. 
3.2.2 Reproducibility – The Trends of RT and Peak Shape  
 One of the most critical factors to reproducibility over a series of injections is the 
ability to regenerate the initial injection conditions.  These initial conditions consist not 
only of solvent composition but also system back pressure.  As read out by the binary 
solvent manager, system back pressure changes or deltas are commonly monitored to 
ensure the stability of fluidics before beginning injections.  Other factors influencing 
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reproducibility in these experiments include on-column carryover and instrument 
condition.   
 The first lesson learned in UHPLC-MS/MS method development with atypical MP 
combinations, compared to “typical” RP-LC MPs, is the importance of a good prime.  
The eventual priming protocol adopted to transition this multi-assay instrument to an 
atypical HILIC/ANP type mixture of mobile was a multi-step process.  First, priming of 
the PEEK solvent lines for several minutes, running to waste, then priming the column 
with a mixture of water and methanol for several minutes and finally priming the column 
at initial conditions for at least thirty minutes.  The reason for this degree of instrument 
set-up was the result of accidentally trying some injections on a column that was not yet 




Figure 28.  Three injections in a row without prime.  The same compounds in three 
repeat injections, TICs displayed in all three panes.  The x-axis is listed in minutes – no 
resemblance between the three injections due to unstable chromatography. 
 
 Changes in back pressure with a constant flow rate can result in non-laminar flow and 
chromatographic abnormalities.  While most initial injections were performed after 
several iterations of priming as described above.  On a few occasions, like the data from 
the C18 column in Figure 28, it was clear that an inadequate prime did not produce 
valuable data. 
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 The questions then became how much initial priming is necessary and how long an 
equilibration time is necessary to regenerate the low deltas in the binary solvent manager 
pressure readout to achieve reproducibility.  Unfortunately, this is still a question that 
remains to be answered as reproducibility was a challenge throughout the project and 
remains a focus of future work.  The reality was that some days the priming protocol 
above would result in deltas in the < 10 PSI range.  However, at other times, the 
instrument could prime for over an hour and not stabilize below a delta of 200 PSI.  This 
inconsistency made some days tend toward troubleshooting rather than data collection; 
some of these tips will be discussed.  Other than the instrument issues discussed 
subsequently, the miscibility of ethyl acetate, acetonitrile, water, and high salt 
concentrations proved challenging.  The salt concentrations used in the experiments 
included 100 mM ammonium acetate with 1 % formic acid, infused at a relatively high 
flow rate on a small internal diameter column resulted in high back pressure.  
Experimental conditions resulted in back pressure approaching the instrument maximum 
15,000 PSI.  This considerable variation could be explained by a potential solubility issue 
with the high salt concentration and ethyl acetate, resulting in an on-column salting-out 
that could take several volumes of a more polar solvent to flush out.   
 Three instrument issues confounded reproducibility and led to a good deal of 
deliberation, but ultimately were fixed and still did not result in absolutely stable 
chromatography.  One of the issues was potential turbulence at the column installation 
point, which involved re-seating the column with the appropriate hardware and 
determining there was no dead space.  As several other individuals used this instrument, 
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at one point, a turbulence check on the front end of a column revealed a missing ferrule, 
which created a conical dead space and mixing.  The ferrule was easily re-installed and 
checked regularly after that.  Instrument issue number two, a dirty skimmer cone, was 
caused by the use of high salt concentration, lengthy infusions, and the high flow rate 
with aqueous solvents (Figure 29).  
 
Figure 29.  Dirty skimmer cone (left).  Clean skimmer cone and cone (right).  A 
consequence of the high salt concentration used in the MP mixture was constantly 
dirtying the skimmer cone. 
 
 At various times in method development, the response would drop, and background 
would increase, but regular cleaning of this skimmer cone would significantly ameliorate 
that issue.  The eventual protocol adopted was to install a clean cone at the beginning of 
the day and clean the old one to re-install at the end of the day.  Method development is 
an aggressive process from the instrument’s perspective, and care must be taken to reduce 
the number of extraneous variables impacting results.  The final instrument issue that 
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resulted in some unstable MS/MS signals initially and a total instrument downtime 
subsequently was the ESI capillary probe being pushed out at a high flow rate.   
 How long the probe was loose is tough to say, but the eventual push that caused it to 
dislodge fully was a column prime at 2 mL/min flow rate that should have gone to waste, 
but the divert valve was in the wrong position.  This costly error caused the ESI capillary 
probe to extend deep into the source housing, and instead of spray, as electrospray is 
known for,  there was dripping of liquid directly onto the cone shown in Figure 30.   
 




 The tip of the ESI capillary is supposed to protrude 0.5 mm, but as shown in Figure 
30, it was hanging well past the skimmer cone, and the liquid was running down it.  The 
probe was rebuilt to specifications and re-installed with no lasting damage to the 
hardware, yet this caused some of the data acquired directly before the dislodge to be 
unusable as it showed a great deal of variation in response at the detector, likely due to 
the presence of liquid on the cone.  While these instrument issues in hindsight may seem 
mundane, they result in lengthy troubleshooting until they are solved, often distracting 
from actual data trends. 
 All days did not require troubleshooting, fortunately.  Some days showed clear 
reproducibility trends across the various column chemistries.  The two-injection series 
shown in Figure 31 and Figure 32, are both for four serial injections of MMA-d3 at         
1 µg/mL.  The two column chemistries compared are C18 in Figure 31 and DH in 32.  
For both of these injection series, all method parameters are held constant, as described in 
Section 3.2.1.   
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Figure 31.  C18 repeat injection series.  The chromatograms are shown in ascending 
order, with the lowest displayed injection 1 being the first and injection 4 being last and 
displayed at the top of the figure.  The x-axis has the time displayed in minutes.  All data 
shown were obtained on the same C18 column. 
 
 It can be seen in Figure 31 that the peak shape for MMA-d3 gets worse as the 
injections progress.  The shoulder becomes more pronounced with each repeat injection, 





Figure 32.  DH repeat injection series.  The chromatograms are shown in ascending 
order, with the lowest displayed injection 1 being the first and injection 4 being last and 
displayed at the top of the figure.  The x-axis has the time displayed in minutes. 
 
 The initial peak shown in Figure 32 at the bottom labeled 1 is broader and tailing 
slightly, indicating the column’s inadequate priming.  However, by the fourth injection 
(top), peak shape is significantly improved, and there is no carryover evidence.  The 




injecting MMA four times, followed by injecting only MMA-d3 four times.  It could be 
seen that MMA carried over, RT of 0.89, into the first injection of MMA-d3 at a 
relatively high quantity indicating the need for additional column washes (Figure 33). 
 
 
Figure 33. Carryover of MMA on C18 column.  Displayed is a TIC in the bottom pane, 
with two peaks, one at 0.89 minutes and one at 1.57 minutes.  The four panes above show 
MMA and MMA-d3 m/z transitions, respectively.  The x-axis displays the time in 
minutes. 
 
 It is observed that the MMA from the previous injection is still present on the column 
and elutes out at 0.89 minutes.  While the MMA-d3 peak elutes out at 1.57 mins, as 
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indicated by the m/z transitions as displayed in Figure 36.  The subsequent injections 
would show that the MMA peak at 0.89 minutes disappears, but a shoulder develops on 
MMA-d3 (Figure 31).  This potential for carryover combined with poor reproducibility 
would require extra volumes of column wash, whether done as part of re-equilibration or 
as a blank injection every few samples, would prolong the run time and make for a less 
useful clinical method. 
 Ultimately, lengthy priming and fastidious cleaning of instrument components 
allowed for some successful days.  However, many puzzling moments, highlight the 
inexperience with method development inherent in the chosen approach.  The method 
arrived at is a preliminary method that has shown promise.  However, there are still days 
where the reproducibility of retention time has proven unattainable, and no clear 
explanation can be given, across multiple columns.  The miscibility of ethyl acetate, 
acetonitrile, and water is not ideal, and resulted in some unstable back pressures, even 
after lengthy primes.  In Figure 34, the pressure trace of the binary solvent manager over 
10 minutes is shown.  After significant priming, the LC conditions for this image are 
0.750 mL/min ethyl acetate on a DH column.  The delta values were low generally, < 10, 
but occasionally showed significant deviations.   The BSM pressure trace showed an 
upward trend at times and an erratic line at other times, not a stable level trace, as is 
expected when priming for initial injections.  The data shown in Figure 34, top and 
bottom, were obtained on separate days but highlight the variability in instability 




Figure 34.  BSM back pressure issue with ethyl acetate prime.  The y-axes are both PSI; 
the x-axes are both the time in minutes with about ten minutes of data shown in each plot.  
The unstable system pressure displayed a wide range of trends and unpredictability.   
 
 Different hypotheses for this issue were discussed previously, and it is currently an 
ongoing issue with this method.  Modifications have been made to the gradient and re-
equilibration parameters, yet this issue persists.  It is possible that high salt concentrations 
on the column, combined with quick changes in MP composition to ethyl acetate resulted 
in salt solubility issues.  It is also possible to run at elevated column temperatures or   
pre-mix some of the solvents like a 95:5 ethyl acetate:water loading MP may have helped 
the back pressure issues and resulted in more stable chromatography.  There was a slight 
back pressure improvement when using a lower salt MP, such as 10 mM vs. 100 mM 
ammonium acetate.  The lower salt MP resulted in more consistent retention times and 
will be discussed in section 3.2.4. 
3.2.3 Selectivity and Resolution  
 Moving towards the ultimate goal of developing a clinical method that can separate 
and quantitate SA and MMA by LC-MS/MS ,several injections were performed across all 
three columns with a sample mixture of all three analytes.  All three analytes were mixed 
in MeOH to a 1 µg/mL concentration and injected to measure selectivity and resolution 
values.  The injections are displayed in Figures 35-37, with the TIC in the bottom pane, 
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and the most robust transition for each compound shown in the three panes above that.  
Figure 35 shows the data for the BEH-Amide column.  Figure 36 shows the data for the 
C18 column.  Figure 37  shows data for the DH column. 
 
Figure 35.  BEH-Amide all 3 analytes.  One injection, TIC at the bottom, all three 
compounds shown by their dominant transitions above.  The x-axis is time in minutes. 
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 The SA* peak, represented by 2,2 dimethylsuccinic acid, is sharp by all three column 
chemistries, however, comparing the MMA and MMA-d3 peaks show a different picture.  
The peak shapes for MMA and MMA-d3 in Figure 35 are quite problematic, with a large 
fronting skew and clear shoulder.  The selectivity and resolution values for the          
BEH-Amide column, based on this injection, are in Table 11. 
 
 
Figure 36.  C18 all 3 analytes.  One injection, TIC at the bottom, all three compounds 
shown by their dominant transition above.  The x-axis is time in minutes. 
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 Similar to Figure 35, SA* is a nice sharp peak in Figure 36 on a C18 column.   
However, the peak shape for MMA and MMA-d3 has some improvements relative to the 
peak in Figure 35.  The peak shapes for MMA and MMA-d3 are more symmetrical than 
on the BEH-Amide; however, they are incredibly broad, with a peak width substantially 
wider than seen in Figure 37.  The selectivity and resolution values for the C18 column, 




Figure 37.  DH all 3 analytes.  One injection, TIC at the bottom, all three compounds 
shown by their dominant transition above.  X-axis is time in minutes.  100 mM 
ammonium acetate in the MP. 
 
 Figure 37 shows a sharp SA* peak, just like in Figures 35 and 36.  However, it also 
shows relatively sharp MMA and MMA-d3 peaks.  There is a defect in the MMA peak in 
that it has a smaller peak eluting earlier that is not baseline resolved from MMA, similar 
to what is seen in Figure 36 for MMA on C18.  This defect can be improved upon with 
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more chromatographic optimization.  It could likely be accounted for by modifying the 
integration parameters, as it is clearly a second peak and not a shoulder.  The clear 
advantage that DH shows is in the peak width for MMA and MMA-d3, with the sharpest 
most symmetrical peak of all three column chemistries.  The other results that stood out 
for this MP mixture on the DH column were the capacity factor (k) and resolution values, 
which were quite good.  The full summary of chromatographic results in these MP 
conditions across all three columns can be seen in Table 11. 
Table 11.  Summary of Chromatographic Results Obtained with High Salt MP 
Column t0 RTSA* RTMMA kSA* kMMA 𝛼 w1/2 -MMA RMMA 
BEH Amide  1.5 2.5 3.73 0.66 1.48 2.24 0.43 1.69 
XB-C18 0.75 1.4 2.51 0.87 0.97 1.11 0.16 0.45 
DH 0.57 1.65 2.69 1.89 3.72 1.96 0.13 4.70 
(all times listed in minutes) 
 It is interesting to note that while DH did show the highest capacity factor for MMA, 
the sharpest peak, and the best resolution, it did not achieve the best selectivity.  The best 
selectivity was achieved by the BEH-amide; however, the column was twice as long, and 
the run would need to be extended to accommodate a clinical method on this length of the 
column.  In addition, the peak shape would require significant troubleshooting as the 
width and fronting seen on the BEH-amide are the cause of the lower resolution, despite 
having a high selectivity value.  As expected, these analytes are not well suited for 
separation on a C18 column, and the data shows that. 
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 The data displayed is far from a method ready to put into production. However, there 
is promise for Cogent’s DH as a viable stationary phase for the separation of the analytes 
SA and MMA.  While the data is not entirely representative of the endogenous analyte 
mixture, where succinic acid, not 2,2 dimethylsuccinic acid, is likely to be more 
challenging to separate from MMA, the potential is obvious.  To further examine if the 
DH column’s retention exhibited an expected ANP-like behavior as opposed to a HILIC 
retention mechanism experiments varying salt concentration were undertaken and will be 
discussed in section 3.2.4. 
3.2.4 Buffer Salt Concentration to Verify ANP Retention Principles 
 Once the preliminary peak shape and retention times were established with a high salt 
MP composition, the concentration and choice of buffer salt were varied to observe the 
effect on RT and peak shape.  The expectation is that, for an acidic compound on a 
HILIC column, the presence of negatively charged silanols will repel the compound.  By 
increasing the molar strength of the MP salt, counter ions are provided which weaken this 
repulsion and result in increased retention.33  In other words, if the column is retaining 
based on a HILIC retention mechanism the retention time will scale with molarity of the 
MP.  In contrast, retention by an ANP mechanism follows the opposite trend, less salt 
results in greater retention.  Now that the baseline RT has been established at a 
concentration of 100 mM ammonium acetate, decreasing the salt concentration to 10 mM 
and monitoring the effect on RT should provide some experimental evidence as to the 
type of retention mechanism the stationary phase exhibits. The baseline RT at “high salt” 
concentration can be seen in Figure 37.  Keeping all other variables constant, including 
 113 
gradient and all solvents, the buffer additives were decreased from 100 mM ammonium 
acetate with 1% formic acid (Figure 37) to 10 mM ammonium acetate and 0.1% formic 




Figure 38.  10 mM ammonium acetate 0.1% formic acid on DH by transition.  One 
injection, TIC at the bottom, all three compounds shown by their dominant transition 
above.  The x-axis is time in minutes. 10 mM ammonium acetate in the MP. 
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 In Figure 38, it can clearly be seen that the retention time increased substantially for 
both compounds, MMA, and SA*.  However, it can also be seen that the peak shape for 
SA* has deteriorated compared to prior conditions in Figure 37.  One other interesting 
observation with the lower salt concentration was that the retention times became much 
more reproducible, likely due to the decrease in back pressure from miscibility issues 
with ethyl acetate and high salt concentrations.  The reproducibility in peak shape and RT 
can be seen in Figure 39. 
 
Figure 39.  10 mM ammonium acetate 0.1% formic acid on DH repeats (TIC).  Five 
sequential injections at “low-salt” concentration with ammonium acetate, first injection in 
the bottom pane, succeeding injections in ascending order.  The x-axis has time in 
minutes. 
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 The improvements realized by using low salt MP were numerous, increased retention, 
decreased back pressure leading to more reproducible chromatography and RT stability, 
as well as decreased cleaning requirements for the instrument.  However, the peak shape 
for SA* definitely is worse with a clear shoulder and the peak width at half maximum for 
MMA-d3 increased.  The peak width at half max increased from roughly 7.8 seconds to 
9.6 seconds at this lower salt and formic acid concentration.  To try to capitalize on the 
benefits of this lower salt concentration, yet improve upon the peak shape, a different 
buffer salt was attempted.  In Figure 40, all chromatographic conditions were held 





Figure 40.  10 mM ammonium formate 0.1% formic acid on DH by transition.  One 
injection, TIC at bottom, all three compounds shown by their dominant transition above.  
The x-axis is time in minutes.  10 mM ammonium formate in the MP. 
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 In Figure 40 ammonium formate is the new variable, once again at the same 
concentration as the “low salt” ammonium acetate in Figures 38-39.  The ammonium 
formate yields interesting improvements to the peak shape of SA* at “low salt”, while 
keeping the increased retention for MMA and MMA-d3 relative to the “high salt” 
injections observed in Figure 37.  The resolution between MMA and SA* is actually 
improved by ammonium formate, however the peak width at half maximum for MMA-d3 
is about 12 seconds.  The lower salt concentration, this time ammonium formate, once 
again resulted in much more reproducibility in RT, as can be seen in Figure 41. 
 
Figure 41.  10 mM ammonium formate 0.1% formic acid on DH repeats (TIC).  
Repeatability of RT and peak shape look promising with low salt ammonium formate.  
The x-axis has time in minutes.  Three injections in series, lowest pane shows first 
injection. 
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 It should be noted that the signals for MMA and MMA-d3 were greater in the “high 
salt” situation, but this is likely due to the higher formic acid concentration that was 
paired with this high salt MP, rather than the salt itself.  The various retention times, 
selectivity and resolution for the high salt versus low salt MP combinations on DH are 
summarized in Table 12. 
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 The results of this salt experiment on the DH column, confirm that the retention of 
these organic acids is inversely proportional to salt concentration in the MP, which agrees 
with established ANP retention mechanism theory.  It would be interesting to try a 
slightly longer run time and an even lower salt concentration to see if the capacity factor 
would increase even more.  While the capacity factor did increase it did so for both 
compounds which actually made the selectivity decrease.  The decrease in selectivity in 
the low salt concentrations and a slightly broader peak, resulted in a decreased resolution 
as well.  
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4.  CONCLUSION AND FUTURE WORK 
 The purpose of this study was to perform preliminary experiments to guide the 
method development process for a quantitative LC-MS/MS assay for MMA in biological 
samples.  The project proved immensely challenging and humbling due to the early 
results’ inconsistency and the amount of time devoted to instrument troubleshooting, 
which made progress very gradual and non-linear.  The two major aims of the project 
were the MS/MS method development and LC optimization.  In addition to these major 
goals, LC optimization attempts were made to examine if the retention mechanism on DH 
is consistent with ANP theory.   
 The MS/MS method development demonstrated the importance of verifying that 
instrumentation is operating to specifications before beginning actual experiments.  The 
mass accuracy, contamination and software hurdles made early experiments problematic, 
but these challenges eventually were overcome, and a valid mass calibration established 
for low-end ESI negative mode.  Once the instrument was operating as expected, a 
combination of Intellistart and manual tuning successfully found multiple transitions per 
analyte and the MS/MS method was established.  The transitions for MMA and MMA-d3 
were verified by other groups in the literature, using ESI negative mode without 
derivatization as can be seen in Table 2.   
 In addition, the parent ions were the expected [M-H]- ions for these organic acids.  
There is still a good deal of room for improvement in terms of tuning parameters and 
optimizing the elution solvent MP composition to enhance the signal at the MS detector.  
The final m/z transitions, cone voltages and collision energies established by this process 
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can be seen in Table 8.  Although a major challenge for a good portion of the project, in 
many ways the MS/MS method development was simpler than the ensuing LC 
optimization experiments. 
 The LC method development and optimization provided a number of challenges, 
many of which were due to the experimental design.  The attempt to try to optimize one 
gradient and MP composition across three unique stationary phases, representing various 
separation modes, was an ill-fated endeavor.  This approach is not recommended for no 
other reason than the amount of time spent priming the instrument.  Although it is nice to 
be able to compare trends across columns and comment on the differences in selectivity, 
resolution and peak shape, compromises had to be made to choose solvents that would 
work across all three columns.  A wiser approach would have been to choose one column 
chemistry and optimize, iterate and optimize again.  The data obtained were often 
interesting, and each experiment brought questions to the forefront which guided future 
experiments.  However, due to the attempts to make these adjustments and try each 
iteration across all three columns, experiments regularly were delayed.  On the other 
hand, had the three columns and various chemistries not been screened it may not have 
been obvious which to choose.   
 Now that the three separation modes have been compared, a few things can be seen.  
There is potential to chromatographically separate MMA and SA, based on the data 
obtained with SA*.  This separation can be done without derivatization, and detection by 
MS/MS in ESI negative mode is a viable approach.  The comparisons of RP, ANP, and 
HILIC for the chromatographic performance of MMA show the best peak shape, 
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retention, and selectivity by ANP on the DH column with an atypical MP mixture.  The 
C18 column using typical RPLC solvents showed no analyte retention, as expected, due 
to the polarity of the analytes.  The experimentation with ethyl acetate as a loading MP 
and 80:20 acetonitrile:water as an elution MP with 100 mM ammonium acetate and 1% 
formic acid showed promising initial results across all three columns.  The preliminary 
gradient and MP composition were only intended to be a starting point.  However, with 
many successive iterations due to various challenges, the progress was not as rapid as 
expected.  There are many unanswered questions and many variations that were untested, 
due to time, availability of solvents/reagents and need for troubleshooting.   
 When comparing all the data collected it is clear the best chromatographic 
performance for MMA is on the DH column, namely the high capacity factor, sharp peak 
and high resolution at high salt concentrations.   Several trends were noted for various 
MP conditions that could assist future method development experiments for these 
compounds.  For instance, at high salt concentrations the BEH-Amide showed the best 
selectivity among the conditions tested, with a value of 2.24.  While the BEH-Amide did 
not perform well based on other metrics, it shows promise for separating these 
compounds that could likely be further refined with optimization experiments.  Another 
notable trend was the increase in capacity factor at lower salt concentrations on the DH 
column, which suggests trying various salt concentrations, from 0.5 mM up to 150 mM at 
regular intervals, to see the true optimum in capacity factor and resolution.  These lessons 
learned can be thought of as leads for future experimentation.  In many circumstances, 
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only extremes of various conditions could be tested, not an ideal way to optimize as 
promising trends may go unnoticed.  
 The most stable chromatography with a good capacity factor and resolution was at the 
lower salt, the 10 mM ammonium formate or ammonium acetate and 0.1% formic acid 
elution combination for the elution MP.  However, no attempts were made at different 
ammonium formate concentrations or at the same concentration but with various acid 
concentrations to improve the ionization efficiency.  While RT was stable at the lower 
salt concentrations the peak shape was not quite as good, suggesting perhaps somewhere 
between 10 mM and 100 mM may be the ideal salt concentration.  The peak shape when 
using a low salt concentration of ammonium formate is promising and warrants further 
investigation. 
 Even though there were issues with repeatability, the sharpest peak, and the best 
response were at high salt and acid concentration, 100 mM ammonium acetate with 1% 
formic acid.  This MP combination resulted in an MMA-d3 peak with a peak width at 
half maximum of 7.8 seconds, but the RT stability was not as good as what was observed 
with the low salt concentration or with acetonitrile:water as the loading MP.  The 
increased concentration of formic acid was likely beneficial for the MS/MS response, yet 
no experiments were performed at low salt but with higher acid content, which would be 
interesting. 
 The salt concentration experiment provided some interesting commentary on the clear 
difference between ANP and HILIC retention mechanisms.  The terms HILIC and ANP 
were often conflated in literature until the last decade as more seminal works have come 
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out that delineate the two.  Despite the recent published works which can point at clear 
differences in retention mechanism, there is not a large amount of experimental data or 
applications that clearly illustrate these theoretical principles.  The salt concentration 
experiment did just that; lowered salt concentration resulted in increased retention.   This 
inverse relationship makes a clear point that DH does not operate by a HILIC retention 
mechanism.  The distinction is critical as it will guide future optimization experiments 
and provide theoretical backing to understand the results.  The LC optimization is 
iterative, and future iterations should move away from the three-column approach and 
focus on the DH as the most promising column chemistry tested.  Although the goal of a 
fully optimized LC-MS/MS method for the quantitative measurement of MMA was not 
realized, significant progress was made towards understanding MMA’s chromatographic 
behavior on the DH column.  
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